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Abstract 
Roles of PPARγ and Lactate Metabolism in The Hypoxic Response of Trophoblasts 
 
Tiffany Marie Bernardo, PhD 
 
University of Pittsburgh, 2020 
 
 
 
Normal placental development and function is critical for the viability and growth of the 
developing embryo.  Oxygen gradients are a key determinant in normal placental development, as 
evidenced by the severe defects in placentas deficient for the transcription factor Hypoxia-
Inducible Factor α (Hif1a) and its regulators.  Additionally, aberrant oxygenation is a frequent 
driver of placental pathologies, including intrauterine growth restriction and preeclampsia.  
Placentas deficient for the nuclear receptor Peroxisome Proliferator-Activated Receptor γ (Pparg) 
exhibit severe, lethal vascular defects that strongly resemble those in knockouts of HIF1α pathway 
genes.  This dissertation establishes that PPARγ is essential for sustained HIF1α activation and 
survival of trophoblasts during acute hypoxic exposure.  Hypoxia necessitates a switch from 
aerobic respiration to glycolytic metabolism, which is largely mediated by HIF1α target genes, 
augmenting lactate synthesis.  Importantly, placental PPARγ strongly regulates Lactate 
Dehydrogenase B (Ldhb) and Pyruvate Carboxylase (Pcx), two enzymes whose tandem action 
converts lactate to oxaloacetate.  Metabolomic profiling revealed significantly elevated levels of 
both L-lactate and pyruvate in PPARγ-null trophoblast stem cells cultured under acute hypoxic 
conditions.  Moreover, pharmacological manipulation of anaerobic glycolysis inhibited the 
sustained activation of HIF1α, PPARγ and additional downstream proteins in hypoxic trophoblast 
cultures.  Stable human trophoblast cell lines engineered to lack key hypoxia regulatory proteins 
were used to further delineate the PPARγ-HIF1α axis.  In vivo, analyses of the effect of Ldhb 
deficiency on vascular development of placentas subject to hypoxic stress found that whereas 
 v 
Ldhb-null and WT placentas are grossly similar in normoxic pregnancies, Ldhb deficiency 
ameliorated vascular anomalies in placentas from hypoxic pregnancies.  These data implicate 
PPARγ as a crucial player in the hypoxic adaptation of trophoblasts.  We further hypothesize that 
PPAR regulates the HIF1 axis, in part, by controlling the intracellular levels of lactate and its 
metabolites. 
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Preface 
The basis for the dissertation before you set out to answer one simple question – why do 
Pparg-null embryos die?  What started out as a relatively straightforward path rapidly devolved 
into a labyrinth (no pun intended) of seemingly endless alternative routes, side projects, and 
exciting possibilities.  Oftentimes, it felt as though there were more questions than answers, which 
solidified the idea that we had uncovered just the tip of a massively intricate and complex iceberg.  
While this dissertation certainly doesn’t contain all the answers, I hope it enlightens the reader on 
the critical role of a PPARγ-HIF1α axis in placental development, and inspires future research on 
the topic. 
 
To all of my friends and family - Thank you for your unwavering support, love, and laughter 
through all the years of this crazy ride.  I wouldn’t have been able to do it without you. 
Tali and Fran – Thank you for being so many wonderful things.  You both have acted as 
my mentor, problem-solver, shoulder to cry on, and support system.  It meant the world to me. 
To my committee members – Thank you for all of the thoughtful conversations and helpful 
discussions.  You all have helped shape this project into something I’m extremely proud of. 
Yaki – There aren’t enough words.  Thank you so very much for all of your guidance, 
support, patience, advice, and ultimately, friendship.  You’ve made me a better person.   
 
Though the course may change sometimes, 
rivers always reach the sea. 
–Led Zeppelin
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1.0 Introduction 
1.1 The placenta is essential for mammalian embryogenesis  
The evolution of a maternal-fetal transport interface is a recent pregnancy adaptation that 
is critical for prolonged intrauterine mammalian embryogenesis (Maltepe and Fisher, 2015).  Early 
in gestation, the developing conceptus fulfills its bioenergetic requirements via facilitated diffusion 
of glucose, pyruvate, and lactate (Gardner and Leese, 1988).  As gestation progresses, the 
nutritional demands of the developing embryo exceed the limits of diffusion and necessitates the 
formation of an efficient transport interface (Brett et al., 2014).  The placenta functions as bridge 
between maternal and fetal vascular compartments, and facilitates the bilateral exchange of gases, 
nutrients, and waste (Lewis RM et al., 2012).  In addition to its transport functions, the placenta 
secretes hormones essential for pregnancy maintenance, and confers immune protection to the 
developing fetus (Delorme-Axford et al., 2014).   
Accordingly, defects in placental development or function have dire consequences, and 
often result in fetal growth restriction (FGR), preterm labor, stillbirth, and/or death.  It has been 
hypothesized that placental defects are the underlying cause of first and second trimester non-
chromosomal human pregnancy losses, which affect approximately 20-30% of all pregnancies 
(Ornoy A et al., 1981).  These data were validated by analysis of genetic mutations that cause 
embryonic lethality in mice, confirming that ~60% of all gene knock outs (KOs) that result in 
embryonic death contain placental pathologies (Hemberger M et al, 2001).   Furthermore, of the 
~2.6 million third trimester human stillbirths that occur annually worldwide, it has been estimated 
that as low as 11% or as high as 65% of cases display contributory or causative placental pathology 
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(Kidron D et al., 2009; Ptacek I et al., 2014; Lawn JE et al., 2016).  While mild placenta 
dysfunction in response to environmental conditions can support fetal survival, pregnancies are 
often accompanied by complications such as preeclampsia and FGR.  FGR has been shown to 
increase long-term cardiovascular, neurocognitive, and metabolic disease susceptibility in 
adulthood, illustrating the programming power of placental responses to the intrauterine 
environment (Barker DJ, 2004; Sferruzzi-Perri AN and Camm EJ, 2016;).  Indeed, defects in 
placental development and function represent a major public health problem with a substantial 
economic burden, and efforts to understand the placenta’s role in these disease processes is of the 
utmost importance. 
1.2 Placental development and structure 
Our understanding of placental development and its role in normal pregnancy maintenance 
has vastly expanded over the past few decades, largely due to the advance of gene editing 
technologies (for in-depth reviews, see Rossant and Cross, 2001; Cross JC, 2005; Simmons DG 
and Cross JC, 2005;l Woods L et al., 2018).  Mouse placentation begins on the third day of 
development (E3.5) with the formation of the outermost layer of the preimplantation blastocyst - 
the trophectoderm (TE).  The TE is the first cell type to differentiate in the early embryo and will 
eventually give rise to all trophoblast lineages, which provide the primary functional and structural 
components of the mature placenta.  The inner cell mass (ICM) forms the second of two distinct 
pluripotent lineages in the blastocyst and is comprised of embryonic stem cells (ESCs) that will 
ultimately form all tissues of the embryo proper, including the allantois and fetal vessels (Rossant 
J and Tam PP, 2009).   
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By the time of implantation (E4.5), the TE can be subdivided based on its position relative 
to the ICM.  The mural TE, which lies in opposition to the embryonic pole, terminally differentiates 
and enters into endoreduplicative cycles to form primary trophoblast giant cells (TGCs) that are 
essential for implantation.  In contrast, the polar TE borders the epiblast and continues to 
proliferate in response to ICM-derived fibroblast growth factor (FGF-4), to form the diploid 
extraembryonic ectoderm (ExE) and ectoplacental cone (EPC) of the early postimplantation 
conceptus (Christodoulou N et al., 2019).  A secondary wave of invasive TGCs differentiate from 
the EPC margins post-implantation and drive maternal spiral artery remodeling, while cells of the 
ExE differentiate and expand to form the chorionic epithelium.   
At E8.5 the allantois extends from the posterior end of the embryo and makes contact with 
the chorionic plate, a critical first step in establishment of the maternal-fetal vascular interface.  
Expression of the transcription factor (TF) Gcm1 increases hours after chorioallantoic attachment 
and drives the formation of folds in the chorion.  These folds act as a road map, effectively guiding 
the invading allantoic vessels into a structure that will form the fetal component of the placental 
vascular tree.  As gestation progresses, the fetal vessels and intertwining maternal blood sinuses 
are constantly expanded and refined to produce the labyrinth.  For the purposes of this dissertation, 
the labyrinth is the most relevant layer of the placenta and contains the maternal and fetal 
circulations, which can be likened to oil and vinegar – touching, yet never fully mixed.  Both the 
human and mouse placenta are hemochorial, meaning that the maternal blood directly bathes the 
fetal trophoblasts, yet the maternal and embryonic vasculatures remains separated by a multi-layer 
cell barrier composed of trophoblasts.  In the placenta of the mouse and most other rodents, the 
fetal endothelium is separated from the maternal vascular space by a total of 3 layers - two layers 
of multinucleate syncytial trophoblasts (synT) directly line the fetal endothelium, while an 
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additional layer of polyploid mononuclear cells, aptly termed the sinusoidal trophoblast giant cells 
(sTGCs), line the maternal blood sinuses (Rossant J and Cross JC, 2001; Woods L, 2018).  The 
basic structure of the human placental barrier is referred to as the villus and is comprised of a two 
cell-layer barrier – mononucleated villous cytotrophoblasts (vCTB) directly line the fetal 
endothelium, while a single layer synTs are in contact with the maternal blood (Blundell C et al., 
2016). 
The labyrinth is structurally supported by the more distal junctional zone (JZ) - a compact 
layer primarily composed of spongiotrophoblasts (SpTs) that are thought to originate from the 
EPC of the early embryo, but whose function is still poorly understood.  Intermixed in a sea of 
SpTs are islands of glycogen trophoblasts (GlyTs) whose name accurately implies that they store 
glucose in the form of glycogen, potentially as a fuel source for the embryo during times of rapid 
development (Tesser RB et al., 2010; Knott JG and Paul S, 2014).  Finally, the entire placenta is 
surrounded by a one- to two-cell layer of secondary TGCs that separate it from the maternal 
decidua (see diagram below). 
 
 
Placenta diagram 
Schematic representation of the mature mouse placenta 
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1.3 The role of oxygen in placental development 
Although the placenta develops into a highly vascularized, well-oxygenated tissue by term, 
early placental development occurs in a hypoxic niche that has been shown to be crucial for both 
fetal organogenesis and proper placentation (Dunwoodie SL, 2009).  Hypoxia is defined as a 
decrease in the partial pressure of oxygen (pO2) relative to the normal saturation level.  
Physiologically normoxic levels in most mammalian tissues range from 2-9% pO2 although certain 
tissues, such as the bone marrow, kidney medulla, and thymus, often endure oxygen tensions 
below 1% (Simon MC and Keith B, 2008).  However, oxygen tension is not absolute, and dynamic 
intra-tissue oxygen gradients have been demonstrated to instruct stem cell proliferation, 
differentiation, and maintenance to coordinate embryonic and placental development (Genbacev 
O et al, 1997; Tuuli MG et al., 2001). 
During the first trimester of human pregnancy, the endovascular extravillous 
cytotrophoblasts (EVT) invade the uterine spiral arteries where they degrade resident smooth 
muscle and endothelial cells (ECs) and replace them with a trophoblast lining.  This remodeling 
event converts reactive, high-resistance vessels into passive, high-capacity conduits to establish 
adequate perfusion of the feto-placental unit.  Initially, the remodeled vessels are plugged with the 
endovascular trophoblasts to ensure that the conceptus develops in a relatively low oxygen 
environment (2.5% pO2) (Maltepe E et al, 2015; Weiss H et al, 2016).  This hypoxic niche supports 
embryonic organogenesis and placental angiogenesis, promotes cytotrophoblast proliferation, and 
suppresses trophoblast differentiation, largely due to the activity of oxygen-regulated TFs (see 
sections 1.4 and 1.5) that mediate physiological adaptation to changes in oxygen tension 
(Genbacev O et al, 1997; Simon MC et al, 2008; Tuuli MG et al, 2011).  During this time the 
maternal plasma and endometrial secretions nourish the embryo, but a major switch in oxygen 
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tension occurs at 10-12 weeks as the demand for fuel and oxygen increases.  The endovascular 
EVT plugs disintegrate, blood flow resumes, and the subsequent rise in oxygen tension (8.6% pO2) 
drives cytotrophoblast differentiation and invasion (Rodesch F et al., 1992; Genbacev O et al., 
1997).  There is less information regarding trophoblast plugs in rodent models, however a similar 
remodeling event occurs in the maternal spiral arteries (Rossant J et al., 2001; Dunwoodie SL, 
2018).     
The extensive vascular network is established by E10.5-11.5 in the mouse, and its initial 
formation and continuous expansion throughout gestation is critically dependent on placental 
oxygen sensing mechanisms (Rossant J et al, 2001; Chen DB et al., 2014; Maltepe E et al., 2015;). 
The dependence on the morphogenetic properties of oxygen for proper placentation is also 
discernible in numerous mouse models, as evidenced by the abnormal placental architecture and 
embryonic lethality in numerous KOs of oxygen-regulated genes.  Importantly, mice carrying 
deletions of Hif1α/Hif2α, Arnt, Phd2, Vhl, and Pparg exhibit reduced progenitor cell proliferation, 
impaired vascularization of the presumptive labyrinth, and a drastic decrease in total labyrinth 
volume (Cowden Dahl KD et al., 2005; Kozak KR et al., 1997; Takeda K et al., 2006; Gnarra JR 
et al., 1997; Barak Y et al., 1999).  While embryonic lethality is generally attributed to the arrest 
of fetal vessel invasion, the primary defects often lie in the trophoblast compartment.  The 
labyrinthine trophoblasts are thought to provide a structure into which the invading fetal vessels 
grow, and cross-talk between the mesoderm and trophoblasts further refines feto-placental 
vascularization.  In the absence of proper trophoblast differentiation, i.e., without the road map for 
fetal vessel invasion, the labyrinth fails to vascularize.   
While areas of micro-hypoxia are essential for driving trophoblast differentiation and 
vessel morphogenesis, chronic placental hypoxia in the absence of re-oxygenation severely 
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impairs placental development and function.  Chronic hypoxia is the most common placental 
injury during human pregnancy, with effects that range from FGR to third trimester miscarriage, 
stillbirth, and maternal preeclampsia.  Defects in maternal spiral artery remodeling, arrest of fetal 
vessel invasion, maternal anemia, and/or high altitude pregnancies (elevation >2700m) contributes 
to trophoblast dysfunction and placental hypoxic lesions including villous hypervascularity, 
compensatory placental overgrowth, and reduced remodeling of the maternal vessels (Hung TH et 
al., 2002; Stanek J, 2013).  The increased expression of hypoxia-inducible factor α (HIF1α; see 
below) at the mRNA and protein level, as well as elevated vascular endothelial growth factor 
(VEGF) release from human hypoxic placentas corroborate these findings and implicates oxygen 
gradients and the downstream transcriptional events as key mediators of trophoblast proliferation, 
differentiation, and placental development (Zamudio S et al., 2007).  
1.4 HIFs in placental development 
Hypoxia, whether injurious or developmental, induces rapid, transient changes in 
carbohydrate and lipid metabolism that results in the cessation of oxygen-dependent ATP 
production and a sharp increase in glycolysis.  The increased glycolytic capacity of hypoxic 
trophoblasts is due, in part, to the activity of the HIF family of TFs (Firth JD et al., 1994; Semenza 
GL et al., 1994).  HIF proteins function as heterodimers and are composed of one of three oxygen-
sensitive alpha subunits (HIF1α, HIF2α, or HIF3α), and the constitutively active subunit 
HIF1β/aryl hydrocarbon nuclear translocator (ARNT) (Wang GL et al., 1995; Koh MY et al., 
2012).  HIF1α normally resides in the cytoplasm where its expression is tightly regulated in an 
oxygen-dependent manner.  In the presence of oxygen, HIF1α is hydroxylated by specific prolyl 
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hydroxylase domain-containing proteins (PHD) on two conserved proline residues located within 
the oxygen-dependent degradation domain (ODD) to form two hydroxyprolines, which facilitates 
the binding of von Hippel-Lindeau syndrome protein (VHL).  VHL functions as the substrate 
recognition module of an E3 ubiquitin ligase, and directs HIF1α for polyubiquitination and 
proteasomal degradation (Ohh M et al., 2000; Jaakkola P et al., 2001).  Therefore, under normal 
oxygen tension α subunits of HIFs are degraded.  Under hypoxic conditions, the PHDs are unable 
to hydroxylate HIF1α and the protein is free to translocate to the nucleus.  HIF1α binds its cognate 
hypoxia response element (HRE) as an obligate heterodimer with ARNT to positively regulate the 
expression of numerous hypoxia-responsive gene networks (Koh MY et al., 2012).   
Both HIF1α and ARNT are abundantly expressed in both the human and mouse placenta and 
have been shown to have critical roles in regulating placental development, where oxygen 
gradients play a role in the determination of cell fate (Dunwoodie SL, 2018).  Interestingly, the 
placental architecture in Arnt-/- embryos is severly disrupted.  The null placentas display a smaller 
chorionic plate, decreased progenitor cell proliferation, and decreased vessel density and tortuosity 
in the labyrinth as compared to their WT counterparts.  Embryos die by E10.5 presumably due to 
failure in placental vascularization (Kozak KR et al., 1997).  While the placental defects in HIF1α 
KO embryos are less severe, placental malformations are observed as early as E9.5, and null 
embryos die by E11.0 (Iyer NV et al., 1998; Cowden Dahl KD et al., 2005). The allantois and 
chorion fail to make contact by E9.5 in 31% of Hif1-/- embryos.  In the remaining 69% of Hif1a-
null embryos that had undergone proper chorioallantoic fusion, the fetal vascular density is 
significantly decreased relative to WT placentas, and the vessels appear dilated.  Additionally, the 
pool of SpTs is reduced by about 50% in the Hif1-/- placentas, suggesting that cellular 
differentiation programs are affected (Cowden Dahl KD et al., 2005).  Conversely, Hif2-/- placentas 
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appeared relatively normal when compared to their WT counterparts.  Most notably, they display 
typical fetal vessel invasion patterns, vascular density, and SpT compartment.  However, when 
both Hif1a and Hif2a are absent, the resulting mutants display an identical phenotype to the ARNT-
deficient embryos suggesting redundancy between the two HIF proteins (Cowden Dahl KD et al., 
2005; Maltepe E et al., 2015).  The role of oxygen in cell fate determination was also interrogated 
using mouse trophoblast stem cells (TSCs) - a pluripotent, self-renewing population of trophoblast 
cells derived from the TE of the blastocyst.  In the absence of genetic manipulation, WT TSCs 
cells will differentiate primarily into TGCs, although SynTs and SpTs are present in the culture, 
and differentiation is enhanced when cells are cultured in hypoxic conditions (Tanaka S et al., 
1998).  Notably, ARNT-/-, Hif1a-/-, and HIF2-/- TSCs were unable to differentiate into TGCs or 
SpTs when cultured under standard or hypoxic conditions.  Rather, these cells primarily 
differentiated into SynTs, confirming that oxygen is a major player in trophoblast differentiation 
(Cowden Dahl KD et al., 2005).    
In addition, Phd2-/- and VHL-/- embryos also exhibit gross placental abnormalities.  These 
mutations result in constitutively active HIF, and subsequent embryonic lethality.  Vhl-null 
embryos were indistinguishable from their WT counterparts at E9.5, but viable embryos were not 
recovered past E12.5.  The fetal vessels from Vhl-null embryos failed to invade the presumptive 
labyrinth, and null placentas displayed severe hemorrhaging and necrosis at the implantation site.  
Additionally, there was no evidence of SynT differentiation (Gnarra JR et al., 1997).  Moreover, 
Phd2 KO also resulted in embryonic lethality by E14.5, owing to decreased labyrinth 
vascularization and abnormal invasion of SpTs into the labyrinth (Takeda K et al., 2006).   These 
findings demonstrate that both induction and inhibition of HIF levels are equally deleterious to 
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placental development, and therefore must be tightly regulated to ensure proper trophoblast 
differentiation and placentation.   
1.5 Metabolic adaptations to hypoxia 
While multiple gene networks are activated in response to decreased oxygen tension, the 
pathways that control metabolic adaptation, particularly those that control the synthesis and 
transport of lactate, are the most relevant to this project.  Importantly, placental glucose 
transporters (GLUTs) and glycolytic enzymes increased in response to acute hypoxic injury are 
influenced by HIF1α stabilization.  Studies in transformed human placental cell lines and whole 
villous explants have shown that the expression levels of GLUT1 and GLUT3 are increased during 
acute hypoxic exposure in a HIF1α-dependent manner.  Baumann et al. (2007) confirmed the 
increase in expression correlated to increased transepithelial glucose transport in a time- and dose-
dependent manner in BeWo cells, consistent with previous reports, and demonstrated that anti-
sense oligonucleotides (oligos) directed against HIF1α prevented the induction of GLUT1 and 
GLUT3 in hypoxia.  However, the induction of GLUT1 and GLUT3 was minimal in hypoxic 
human villous explants, possibly owing to their heterogenous nature or the short lifespan of 
placental explants in culture (Hayashi M et al., 2004; Baumann ME et al., 2007).  Additionally, 
Esterman et al. (1997) reported an increase in GLUT1 expression and a subsequent decrease in the 
uptake of [3H] 2-deoxyglucose when trophoblasts were exposed to hypoxic conditions.  This 
discrepancy could be attributed to differences in transepithelial transport versus total cellular 
uptake of glucose, respectively.  
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The elevated uptake of glucose dictates that glycolytic flux must also be increased to keep up 
with cellular demand of energy.  Accordingly, it was discovered that placental HIF1α regulates 
phosphoglycerate kinase 1 (PGK1) in human placental villous samples of pregnancies complicated 
by intrahepatic cholestasis of pregnancy (ICP).  PGK1 catalyzes the first ATP-generating step in 
glycolysis, and its increased expression in complicated pregnancies suggests an increased flux 
through the glycolytic pathway in response to acute hypoxia, the primary suspect in the underlying 
pathophysiology of ICP (Wei W et al., 2014).  This increased glycolytic flux is further enhanced 
by HIF1α-mediated upregulation of pyruvate dehydrogenase kinase 1 (PDK1).  PDK1 
phosphorylates and effectively inactivates the pyruvate dehydrogenase complex (PDHC), thereby 
shutting down mitochondrial respiration and diverting pyruvate for use in other pathways (Kim 
JW et al., 2006). 
Moreover, heightened glycolytic activity is often commensurate with an increase in lactate 
generation.  Indeed, studies have shown a HIF1α-dependent increase in expression and activity of 
the lactate dehydrogenase (LDH) isozyme A4 (LDHA) in response to acute oxygen deprivation in 
transformed human placental cell lines and in the fetal ECs of preeclamptic villi (Tsoi SC et al., 
2001; Kay HH et al., 2007).  LDHA catalyzes the conversion of pyruvate to lactate and, in turn, 
generates the reducing equivalents required for sustained glycolysis and energy generation (Adams 
MJ et al., 1973).  However, excessive lactate is extremely cytotoxic and is exported from the cell 
through HIF1α-dependent upregulation of the proton-coupled monocarboxylate transporter 4 
(MCT4).  MCT4 is localized to the basal plasma membrane of the second SynT layer in the mouse 
placenta, proximal to the fetal endothelium, suggesting that lactate is transported from either the 
maternal circulation or placenta to the fetus.  Conversely, MCT4 is localized to the microvillus 
member of the SynT layer in human placentas (maternal-facing), indicating lactate flux from the 
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embryo into the maternal blood pools.  This dichotomy between mice and humans may be 
attributed to the bi-directional transport capacity of the MCTs depending on the concentration 
gradient of lactate in the mother and fetus (Settle P et al., 2004; Nagi A et al., 2010). 
1.5.1 A new role for lactate? 
Traditionally, lactate is viewed as a dead-end product of glycolysis that is eliminated as 
waste or exported to the liver as a carbon substrate for gluconeogenesis, yet has recently been 
promoted to a bona fide signaling molecule.  Accumulating evidence suggests that hypoxia-driven 
shifts in fuel utilization play a pivotal role in normal microvascular development, where localized 
hypoxic areas promote EC proliferation, migration, vessel morphogenesis, and subsequent 
reoxygenation of the adjacent tissue.  In fact, it has been shown that migratory, hypoxic ECs 
primarily utilize anaerobic glycolysis to generate their ATP supply.  Pyruvate, the end product of 
glycolysis, is reduced to lactate to generate the reducing equivalents for sustained glycolytic flux.  
In addition, lactate functions as a competitive antagonist for α-ketogluterate, a key intermediate of 
the TCA cycle, which inactivates the PHD proteins, and, in turn, promotes HIF-dependent VEGF 
expression.  This mechanism effectively generates a positive feedback loop for enhanced 
angiogenesis (Lu H et al., 2002; Kumar EB et al., 2007; Fraisl P et al., 2009). 
Furthermore, Lee et al. demonstrated that HIF1α-mediated induction of Ldha generates the 
increased lactate load required to bind to and physically stabilize the oxygen-regulated protein N-
myc downregulated gene 3 (NDRG3) during chronic hypoxic exposure.  Stable NDRG3 can then 
signal through the Raf-ERK pathway to promote angiogenesis and subsequent reperfusion (Lee 
DC et al., 2015). Interestingly, human trophoblasts express the close homolog NDRG1, an oxygen-
responsive protein that protects human term trophoblasts from hypoxic insult (Chen B et al., 2006).  
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NDRG1 can also be detected in placentas from pregnancies complicated by FGR and 
preeclampsia, both of which are thought to have pathophysiological roots in abnormal placental 
perfusion (Choi SH et al., 2007).  In addition, it has been demonstrated that Ndrg1-/- female 
embryos exposed to hypoxic conditions are more susceptible to lethality than their male 
counterparts, suggesting that NDRG1 may regulate a sex-specific response to hypoxic injury 
(Larkin J et al., 2014).  NDRG1 can be found in the nucleus within 24 h of hypoxic exposure in 
human term trophoblasts, yet the function, regulation, and termination of this pathway are unclear 
(Shi XH et al., 2013).   
1.6 PPARγ and placental development 
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated TFs with 
fundamental roles in energy homeostasis, cellular differentiation, and inflammation.  Three PPAR 
isotypes encoded by distinct single-copy genes have been identified: PPARα, PPARβ/δ, and 
PPARγ (Kliewer SA et al, 1994).  Alternative splicing and promoter utilization gives rise to two 
primary PPARγ transcripts in the human and mouse; PPARγ1 is expressed in many tissues and is 
the predominant isotype in the placenta, whereas PPARγ2 is localized to adipocytes and the liver, 
and contains a 30 amino acid N-terminal extension via an alternate transcription start site 
(Tontonoz et al., 1995; Lavery DN et al., 2005; Schaiff WT et al., 2006; Fournier T et al., 2007).  
PPARs bind to their cognate response element in the promoters of regulated genes as an obligate 
heterodimer with the retinoid X receptor and activate transcription in response to ligand 
stimulation (Kliewer SA et al., 1994).  As early as E8.5, PPARγ1 expression is exclusively detected 
in the murine trophoblast lineages, including the SpT, SynT, and secondary TGCs, and its 
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expression is not present in the embryo proper until E13.5 (Barak Y et al., 1999).  PPARγ is 
abundantly expressed in human trophoblasts starting at the 7th week of gestation, but information 
regarding the prevalence and significance of PPARγ deficiency in complicated pregnancies 
remains controversial (Meirhaeghe A et al., 2007; Barak Y et al., 2008; McCarthy FP et al., 2013).   
The regulatory functions of PPARγ are critical for extraembryonic tissue development as 
Pparg-null mouse embryos die by E10.0 and are rescued by tetraploid chimeras, confirming that 
death is due to placental malformation (Barak Y et al., 1999).  In normal pregnancy, the chorionic 
basement membrane forms a tight association between the fetal ECs and trophoblast layers, which 
is necessary for embryonic vessel invasion and nutrient exchange.  The basement membrane is 
severely disrupted in Pparg-null placentas, and consequent lack of cohesion between the two cell 
types results in failed fetal vessel permeation and transport through the feto-placental unit.  While 
all layers of the placenta (TGCs, SpTs, labyrinth, and chorion) are intact, the labyrinthine 
trophoblast precursors fail to mature and form the multinucleate barrier essential for efficient 
nutrient exchange and immune protection of the developing embryo. In addition, null placentas 
are entirely devoid of the lipid droplets that typify WT placentas (Barak Y et al., 1999). In pursuit 
of the mechanisms underlying the developmental arrest of Pparg-null placentas, transcriptional 
profiling revealed that the mucin gene Muc1 is a robust target of placental PPARγ.  The MUC1 
protein is localized to the apical surface of the sTGCs that line maternal blood pools, and its 
expression is upregulated upon PPARγ agonist stimulation in mouse TSCs.  However, Muc1-/- 
embryos are viable, and mutant placentas infrequently display minor maternal blood sinus dilation 
at worst (Shalom-Barak T et al., 2004).  While compelling, these findings suggest that the relevant 
PPARγ target genes whose expression is indispensable for placental development remain 
unknown.       
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1.6.1 Transcriptional regulation by placental PPARγ 
PPARγ is a well-established transcriptional regulator of lipid metabolism and glucose 
homeostasis in multiple tissues, including liver, adipose, skeletal muscle, and leukocytes.  
However, the metabolic functions of placental PPARγ have not been fully established (Desvergne 
B et al., 1999; Wahli W, 2002).  Gene microarrays identified numerous PPARγ target genes in the 
mouse placenta, many of which are metabolic enzymes (Shalom-Barak T et al., 2012).  
Importantly, two of the most differentially regulated genes encode lactate dehydrogenase B 
(Ldhb), an enzyme implicated in the conversion of lactate to pyruvate, and pyruvate carboxylase 
(Pcx), an enzyme that converts the pyruvate product of LDHB to oxaloacetate (OAA) and has 
proven functions in lactate clearance, oxidative phosphorylation, and fatty acid (FA) synthesis 
(Takeno T et al., 1989;  Jitrapakdee S et al., 1999; Shalom-Barak T et al., 2012).  In situ 
hybridization of WT and Pparg-null E9.5 placentas showed that Ldhb expression is lost in the 
labyrinth and SpT layers of the null placentas as opposed to its retention in the chorion and 
secondary TGC layers, indicating that Ldhb is developmentally regulated by PPARγ in a cell-type 
specific manner (Shalom-Barak T et al., 2012).  In the human placenta, LDHB expression is 
localized to SynTs, but its function during pregnancy is unclear (Tsoi SCM et al., 2001).  Despite 
its evolutionary conservation across plant, fungi, and animal kingdoms, the molecular regulation 
and physiological importance of the LDH isozyme B4 remains unclear (Nash WG et al., 1982).  To 
date, at least 15 distinct mutations in the human Ldhb gene are known to cause lactate 
dehydrogenase deficiency, but patients are asymptomatic even though the enzymatic activity is 
significantly decreased in cardiac muscle cells (Maekawa M et al., 1994; Sudo K et al., 1994; 
Wakabayashi H et al., 1996; Tanis RJ et al., 1997; Takatani T et al., 2001).  
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Conversely, Pcx deficiency is an autosomal recessive rare inborn error of metabolism with 
three unique clinical presentations: Type A (“North American”/infantile form), Type B 
(“French”/neonatal form), and Type C (“Mild” form).  Types A and B present in infancy or shortly 
after birth, respectively, and are characterized by lactic acidosis, hyperammononemia, liver failure, 
hypomyelination of axons, and neurocognitive delays.  Patients succumb to the disease during the 
neonatal period or early childhood due to multi-system organ failure as a result of severe metabolic 
acidosis (Arnold GL et al., 2001; Garcia-Cazorla A et al., 2006). Type C, often referred to as the 
benign form, is characterized by intermittent attacks of lactic acidosis and moderate neurocognitive 
delays.  The mild clinical presentation is attributed to increased residual PCX enzymatic activities 
permitting patient survival to at least the third decade (Stern HJ et al., 1995; Arnold GL et al., 
2001). The activity of PCX was shown to increase during the fourth and final months of pregnancy 
in sheep placentas, but little is known regarding the distribution or relative contribution of Pcx to 
placental metabolic homeostasis (Edwards EM et al., 1977).  It is tempting to postulate that these 
enzymes instruct placentation via trophoblast metabolic regulation, as none of the targets of 
placental PPARγ are conventional developmental regulators.  
1.7 Thesis hypothesis and major findings 
Given the phenotypic similarity between Pparg-null and Hif1a-null placentas, this study 
was developed to determine if (I) PPARγ and its transcriptional targets modulate key 
developmental and pathological adaptations to placental hypoxia, including the function of 
signaling proteins and tissue vascularization and (II) Enzymes that metabolize lactate play 
important, quantitative roles in these functions.  At the onset of this study the connection between 
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PPARγ and HIF1α in trophoblast hypoxic signaling were yet to be explored.  This thesis 
demonstrates that PPARγ is essential for both sustained HIF1α activation and survival of 
trophoblasts during acute hypoxia.  Interestingly, subsequent studies elucidated a central role of 
lactate metabolism in the hypoxic response of trophoblasts.  The remainder of the dissertation 
explores the intimate details of the PPARγ-HIF1α-lactate axis in trophoblasts.  
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2.0 Materials and Methods 
2.1 Animals 
Adult (6-8 week old) WT C57Bl/6 (B6) and 129SvlmJ (129) male and female mice used 
here were from in-house colonies propagated off of stocks purchased from Jackson Laboratories.  
All procedures for animal care and experimental use were in accordance with the Institutional 
Animal Care and Use Committees of the University of Pittsburgh and Magee-Womens Research 
Institute. 
2.1.1 In vivo analyses 
Ldhb-null mice were generated before the start of this project.  LdhbΔ/+ founders were 
backcrossed onto both B6 and 129 background for several generations before phenotypic analysis.  
LdhbΔ/+ B6 dams and sires were crossed to obtain matched WT, mutant, and null placentas.  
Copulation plugs were used to determine the date of pregnancy (noon on the day of the plug = 
E0.5).  Where applicable, dams pregnant with the product of heterozygous crosses were randomly 
allocated to either hypoxic (12% O2) or standard (21% O2) conditions starting at E9.5  To induce 
placental hypoxia, pregnant dams were reared in an O2- and CO2-controlled hypoxic glove box 
equipped with a purge airlock system, humidity control, and gaseous waste removal (Coy 
Laboratory Products) at 6-day intervals between mid-gestation and term.  Placentas were collected 
at various times and separated from embryos.  Excess decidual tissue was carefully removed, and 
yolk sac tissue was collected for genotyping.  DNA was extracted from yolk sacs and the target 
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allele PCR-amplified with Taqman (Life Technologies) to determine embryo genotype.  
Genotyping oligos: 
Table 1 - Genotyping oligos 
 
2.2 Generation of JEG-3 monoclonal cell lines 
pCW-Cas9 (Addgene) was used to generate a doxycycline (dox)-inducible Cas9 stable cell 
line.  A puromycin (puro)-resistant vector expressing the Dox-dependent activator, rtTa, and a Tet 
response element driven FLAG-tagged Cas9 (Flag-Cas9) was transfected into JEG-3 cells.  
Individual puro-resistant clones were selected, expanded, and incubated in the presence or absence 
of 1 µM dox for two days.  Clones were screened for the expression of Flag-Cas9 upon dox 
stimulation with an α-FLAG M2 antibody (Millipore Sigma).  Clone 5.1 (JEG 5.1) produced high 
levels of Flag-Cas9 when stimulated as compared to undetectable levels at baseline, and therefore 
was selected as the parent clone for all subsequent genetic modifications.   
  Next, a neomycin (neo)-resistant single guide RNA (sgRNA) vector was generated by 
subcloning the guide portion from pLKO5.sgRNA.EFS.GFP (Addgene) into Bluescript using the 
NotI/SalI restriction sites.  Mutant monoclonal cell lines were generated by first priming JEG 5.1 
with 1 µM dox for two days to induce Cas9 expression.  Once primed, multiple sgRNAs directed 
Name Sequence 
Cre FWD GCATTACCGGTCGATGCAACGAGTG 
Cre Rev GAACGCTAGAGCCTGTTTTGCACGTTC 
WT Ldhb FWD CTCCAGGTCTGCAGCTGTATCATCAG 
WT Ldhb Rev TGTGCACCTGTTAGCACAATCTCCA 
Ldhb  TTCCCGTACAGACCGTCATGGC 
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against the target gene were transfected into JEG 5.1 and selected with neo (400 µg/ml) such that 
a single cell that had undergone successful Cas9-mediated gene excision was isolated and 
propagated to generate individual colonies. Clones were screened via PCR, expanded, and further 
validated by probing with antibodies directed against the protein of interest.  All plasmids and 
sgRNAs used are included in Appendices A and B, respectively.   Antibodies used for validation 
are included in Appendix D.  pCW-Cas9 and pLKO5.sgRNA.EFS.GFP were kind gifts from the 
Sadovsky lab. 
2.3 TSC culture 
Undifferentiated WT and Pparg-null mouse TSCs were maintained on a feeder layer of 
mitotically inactivated mouse embryonic fibroblasts (MEFs) in RPMI-1640 medium containing 
20% serum, 1% sodium pyruvate, FGF4 (25 ng/ml; Sigma) and heparin (1 µg/ml).  Media was 
changed every other day until colonies reached adequate size and subsequently passaged for 
various experiments.  For all experiments, TSCs were cultured in feeder-free conditions with MEF-
conditioned TS media supplemented with 20% serum, FGF4 and heparin.  To induce 
differentiation, the FGF4 and heparin pressure was removed, and cells were cultured for three days 
in the presence or absence of various ligand combinations before experimental manipulation.  
Ligand concentrations are detailed in Appendix E. 
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2.4 In vitro hypoxia exposure 
JEG-3 and differentiated TSCs were cultured under hypoxic conditions (<1% O2) for 6-72 
hours in the presence or absence of various ligands or inhibitors of lactate metabolism as described.  
For pharmacological studies, cells were first pre-treated with inhibitors and/or exogenous L-lactate 
for 1 hour under standard tissue culture conditions before hypoxic exposure.  When necessary, cell 
culture media was equilibrated for 24 hours in the hypoxia chamber.  Media was changed every 
other day until cells were collected for further processing.  All chemicals and the concentrations 
used are listed in Appendix E. 
2.5 Preparation of whole cell lysates and Western blotting 
Placentas were collected from WT, heterozygous, and Ldhb-null mice, immediately snap-
frozen in liquid nitrogen, and stored at –80C.  Cells were washed, scraped in ice-cold PBS, 
pelleted, and stored at –80C.  Whole placentas and cell pellets were extracted in lysis buffer (50 
mM Tris pH 8.0, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40, 25 µg/ml aprotinin and leupeptin, 
1.25 mM phenylmethylsulfonyl fluoride [PMSF]), and cleared by centrifugation. 
For Western blotting, all samples were diluted, supplemented with 4x Laemmli buffer 
containing β-mercaptoethanol, and fractionated on a 10% denaturing acrylamide gel.  Proteins 
were transferred onto a nitrocellulose membrane and probed with various antibodies.  Bands of 
interest were detected by chemiluminescence according to manufacturer’s instructions 
(ThermoFisher Scientific).  β-actin was used as a loading control.  All primary antibodies and their 
dilutions are listed in Appendix E. 
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2.6 Expression analyses 
RNA was extracted from TSCs using the Trizol method.  RNA quality and purity were 
confirmed by a formaldehyde gel and nanodrop analysis, respectively, prior to quantitative 
complementary DNA (cDNA) synthesis.  RT and quantitative PCR (qPCR) were performed with 
qPCR kits from Applied Biosystems according to manufacturer’s instructions, and samples were 
run on a CFX96 Touch thermocycler from Bio-Rad Laboratories.    Oligo pairs for each gene of 
interest were based on Primer Bank whenever available or designed using the Primer3 shareware.  
qPCR reactions were normalized to the Dazap1 gene, which was relatively unchanged over the 
course of TSC differentiation and Rosi treatment as identified in the lab’s extensive screens.  
Relative expression levels were transformed to a linear scale by the ΔΔCT method and analyzed 
with a one-way analysis of variance (ANOVA) and Tukey’s post hoc test (Livak et al., 2001).  
Expression under standard tissue culture conditions in the absence of Rosi was assigned a relative 
value of 1.0.  Pparg, Muc1, and Dazap1 oligo pairs used were described previously (Shalom-Barak 
T et al., 2012).  Additional oligo pair sequences are as follows: 
 
Table 2 - qPCR oligos 
Name Ref # Sequence 
mHif1a FWD qPCR 2018 
ACCTTCATCGGAAACTCCAAAG 
mHif1a Rev qPCR 2019 
CTGTTAGGCTGGGAAAAGTTAGG 
mNdrg1 FWD qPCR 2020 
ATGTCCCGAGAGCTACATGAC 
mNdrg1 Rev qPCR 2021 
CCTGCTCCTGAACATCGAACT 
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2.7 Gross morphology 
Whole placentas were fixed overnight (O/N) at 4C in neutralized 4% paraformaldehyde 
(PFA), transferred to 70% ethanol (EtOH) O/N at room temperature (RT), dehydrated in a graded 
EtOH series, and embedded in paraffin wax.  Midline cross sections (5 µm) were stained with 
hematoxylin and eosin (H&E). 
2.8 Immunofluorescence 
Dams pregnant with LdhbΔ/+ intercrosses were reared in 12% O2 from E9.5-15.5.  Whole 
placentas were harvested, fixed in neutralized 4% PFA O/N at 4C, transferred to 30% sucrose 
O/N at 4C, and embedded in OCT.  Midline sections (10 µm) were permeabilized with neutralized 
4% PFA for 15 minutes at RT and stained with mouse α-CD31 (eBioscience) and Armenian 
hamster (AH) α-MUC1 (ThermoFisher Scientific).  The following day, slides were washed and 
stained with Rat α-mouse AlexaFluor555 and goat α-AH AlexaFluor488 for 1 hour at RT.  Slides 
were washed, counterstained with DAPI, and mounted for fluorescence.   
Images were acquired on a Nikon A1 (s216.3) confocal microscope equipped with a 
motorized stage and 20x objective to collect stepwise images.  The acquired image tiles were 
stitched together to generate a comprehensive overview of the vascular structures.  The total 
labyrinth area was quantified on whole area scans in the program Nis Elements (Nikon Instruments 
Inc.).  Briefly, binary masks were generated by defining thresholds on each individual channel.  
Masks were overlaid to calculate the proportion of the labyrinth, comprised of the maternal blood 
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spaces (green) and fetal vessels (red), to the total placental area.  Values were analyzed for 
significance with a two-way ANOVA and Tukey’s multiple comparisons test.      
2.9 Lactate analysis 
Samples were washed with ice-cold PBS, scraped in ice-cold 8% perchloric acid to quench 
metabolic processes, and cleared by centrifugation.  Supernatants were collected, neutralized with 
dropwise addition of 3 mM potassium carbonate, and cleared by an additional round of 
centrifugation.  Supernatants were aliquoted, snap-frozen in liquid nitrogen and stored at –80C.  
Undiluted samples were analyzed using the Amplite Fluorimetric assay kit exactly according to 
manufacturer’s instructions (AAT Bioquest). Values were analyzed with either a one-way 
ANOVA and Dunnett’s post hoc test or two-way ANOVA and Tukey’s multiple comparisons test, 
as described in the text.   
2.10 Metabolomics 
Differentiated WT and PPARγ-null TSCs were cultured in triplicate under standard 
conditions and < 1% O2 for 12 hours as described.  Plates were subsequently washed with ice-cold 
PBS, scraped in ice-cold 80% methanol (MeOH) to quench metabolic processes, and cleared by 
centrifugation.  The cell pellets were re-extracted, cleared by another round of centrifugation, and 
pooled.  Samples were sent to the University of Minnesota for untargeted metabolomics using LC-
MS/MS Selective Reaction Monitoring (SRM) analysis of compounds. Samples (10 µl) for SRM 
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analysis were subjected to separation using a Shimazo column to an analytical SeQuant ZIC-
pHILIC (150mmx4.6mm at 30C) connected to the Applied Biosystem 5500 iontrap fitted with a 
turbo V electrospray source run in negative mode with declustering potential (DP) and collision 
energies (CE) in table 3. The samples were subjected to a linear gradient of 80%B to 25%B over 
a 18 minute gradient (A: 10mm ammonium acetate pH7, 20% acetonitrile 0 B:  Acetonitrile) at a 
column flow rate of 400 µl /min.  The column was cleared with 25 % B for 2 minutes and then 
equilibrated to 80% B for 10 minutes.  Transitions monitored as in table 3 were established using 
the instrument’s compound optimization mode with direct injection for each compound. The data 
was analyzed using MultiQuant™ (ABI Sciex Framingham, MA) providing the peak area. A 
standard curve was constructed using in 10 µl. Samples were run once and concentrations 
determined from the standard curve.  Values were analyzed using a two-way ANOVA and Tukey’s 
multiple comparisons test.   
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Table 3 - Seperation and detection specifics for measured analytes 
2.11 Statistics 
One- and two-way ANOVA were used to determine P-values in Graphpad Prism.  A P 
value of <0.05 was considered significant in all experiments.  Error bars designate standard 
deviation (sd).   
ID Q1 Q3 DP CE 
ACoA_408 808 408 -45 -40 
ACoA_461 808 461 -45 -40 
alphaKeto_101_Q 145 101 -50 -21 
alphaKetp_57_V 145 57 -50 -25 
ATP_159 506 159 -50 -45 
ATP_408 506 408 -45 -30 
Lactate_41V 89 41 -70 -16 
Lactate_43Q 89 43 -50 -16 
Malic Acid 7_V 133 71 -50 -14 
Malic Acid_Q 133 115 -50 -20 
PEP_63_V 166.9 63 -30 -30 
PEP_79_Q 166.9 79 -75 -35 
Pyruvate_Q 87 43 -50 -12 
Succinic Acid_100 117 100 -65 -26 
Succinic Acid_73 117 73 -65 -16 
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3.0 Results 
3.1 PPARγ is required for sustained HIF1α protein expression in hypoxic trophoblasts 
The positive regulation of Ldhb and Pcx by placental PPARγ, and the absence of 
conventional developmental regulators or differentiation target genes, raises the intriguing 
possibility that lactate metabolism may play a role in proper placentation.  Although lactate can 
be produced under steady-state conditions, the bulk of lactate is generated in the absence of 
oxygen, during which the TCA cycle is shut off and the conversion of pyruvate to lactate is required 
for generating the reducing equivalents for sustained glycolysis and ATP production (Ferguson 
BS et al., 2018).  This metabolic switch is largely achieved through the activity of stabilized HIF1α 
and its target gene regulation.  HIF1α increases the expression of PDK1 and LDHA, which are 
responsible for inactivating the TCA cycle and promoting lactate production, respectively.  Given 
the essential role of HIF1α in the cellular response to hypoxia, and phenotypic similarities shared 
by Pparg-null and Hif1a-null placentas, studies were initiated to determine if there was a 
relationship between these two proteins. 
3.1.1 Pparg is required for sustained expression of HIF1α protein in hypoxic TSCs 
Because placental development occurs in a relatively hypoxic environment prior to the 
formation of the labyrinthine vascular tree, WT and Pparg-null TSC lines were used to determine 
if there is a relationship between PPARγ and HIF1α in hypoxic trophoblasts.  TSCs were 
differentiated for 3 days in the presence or absence of the PPARγ agonist Rosiglitazone (Rosi; 1 
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µM) and cultured under either standard (21% O2) or hypoxic (<1% O2) conditions.  In WT TSCs 
HIF1α expression was increased dramatically at 24 h post hypoxia exposure and this induction 
was further enhanced by Rosi (Figure 1A lanes 5 and 6).   
Concomitant with a decline in PPARγ levels at 48 h post hypoxic exposure, HIF1α levels 
also decreased (lane 7). This decrease was mitigated by the addition of Rosi (lane 8), suggesting 
that PPARγ positively regulates HIF1α induction in hypoxia.  As shown previously, PPARγ levels 
declined slightly in WT cells treated with Rosi (lane 3), possibly reflecting negative feedback 
regulation (Shalom-Barak T et al., 2004; 2012).  Compared to the WT counterpart, HIF1α 
expression was completely absent in Pparg-null TSCs within 24 h of exposure to hypoxia (lane 
4).  Pparg-null TSCs exhibited variable lethality throughout the course of this project, ranging 
from complete death by 24 h to survival past 48 h in hypoxia.  While the intimate details of this 
phenomenon were not explored, the overall trends in the expression of hypoxia-regulated proteins 
remained the same.   By 48 h in hypoxia, Pparg-null cells have all died, possibly due to a lack of 
HIF1α at that time point, obviating protein analyses.  Importantly, an inverse relationship between 
PPARγ and NDRG1 was observed.  NDRG1 levels were maintained at near-zero in normoxic   
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Figure 3-1 - PPARγ is required for sustained HIF1α expression. 
WT (GY11) and Pparg-null (GY9) TSCs were differentiated for 3 days and cultured under standard or hypoxic 
conditions for (A) 24 or 48 h or (B) and (C) 0 – 6-48 h in the presence or absence of the PPARγ agonist Rosi (1 µM).  
(A) HIF1α expression levels at 24 and 48 h post hypoxic exposure respond to Rosi and are completely absent in Pparg-
null TSCs.  (B) and (C) PPARγ is required for sustained HIF1α expression between 12 and 48 h post hypoxic exposure.  
Additionally, PPARγ appears to negatively regulate the hypoxia response protein NDRG1.  β-actin confirms equal 
sample loading in all lanes. 
 
 
trophoblasts (lane 2), as previously reported (Shi XH et al., 2013), and were further suppressed by 
Rosi (lanes 3, 6, 8).  In contrast, the absence of PPARγ promoted NDRG1 expression in normoxic 
TSCs (lane 1), and further augmented NDRG1 levels in hypoxic cultures relative to WT TSCs 
(lane 4). Both results are consistent with negative regulation of NDRG1 by PPARγ.  Expression 
of the intracellular C-terminal 2 (CT2) domain of the PPARγ target MUC1 declined over time in 
both WT and Pparg-null hypoxic TSCs.   
It has been previously shown that HIF1α protein can be detected in cancer cell lines as 
early as 4 h post hypoxia exposure, rapidly declines starting at 24 h, and is nearly undetectable in 
most cells around 48 h (Lee DC et al., 2015). This raised the question whether HIF1α absence 
from Pparg-null TSCs at the 24 h time point reflects total failure to induce HIF1α or a different 
induction and decay kinetics.  Figures 1B and 1C roughly recapitulated this reported kinetics in 
WT TSCs (1B lanes 4-14; 1C lanes 1-10).  In contrast, although Pparg-null TSCs strongly 
expressed HIF1α at 6 h post-hypoxia (1B lane 2; 1C lane 12), its levels sharply declined by 12 h 
(1B lane 3; 1C lane 13).  Although in the experiment shown in Figure 1B, no TSCs survived by 
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24h, and therefore, protein kinetics could not be analyzed, in the one shown in Figure 1C the cells 
survived for over 48h, enabling analysis at a later time point; here, HIF1α was completely absent 
by the 24 h time point (1C lane 14). 
It is noteworthy to highlight the shift in HIF1α doublet formation in Rosi-treated WT (1B 
lanes 10, 11; 1C lanes 7, 8) and Pparg-null (1B lane 2; 1C lane 12) hypoxic TSCs to a singlet 
protein (1B lane 3, 12; 1C lanes 9, 13).  Although the exact nature and composition of this doublet 
is has not been analyzed by us or others, its differential behavior in the context of TSCs and PPARγ 
suggests a potential functional significance.    
  These extended protein kinetics experiments further validated the direct relationship 
between PPARγ and HIF1α and confirmed the decline of Muc11 in hypoxia.   
3.1.1.1 Validation of the PPARγ-HIF1α axis 
TSCs are a primary pluripotent mouse cell line derived from the TE of individual 
blastocysts and, due to the stochastic nature of their derivation, carry the hypothetical risk of being 
highly variable in their molecular and biochemical responses.  The hypoxic responses of one 
additional Pparg-null clone (GY20) and two additional WT lines (Clone 2 and TRF) were 
interrogated to rule out the possibility of clonal artifacts (Figure 2).  By 6 h in hypoxia both WT 
cell lines had increased HIF1α expression (lanes 5, 18, 21).  By 12 h post hypoxia, HIF1α levels 
were sustained in the WT TRF line (lane 21) but nearly diminished in Clone 2 (lane 8), highlighting 
the variable hypoxic response of TSCs.   In both WT lines, HIF1α levels declined significantly by 
24 h in hypoxia (lanes 10-13, 23-26).  Nevertheless, this decrease was mitigated by the addition of  
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Figure 3-2 - Additional clones validate PPARγ-HIF1α axis in hypoxic trophoblasts. 
WT (Clone 2 and TRF) and Pparg-null (GY20) TSCs were differentiated for 3 days in the presence or absence of 
Rosi (1 µM) and cultured under standard or hypoxic (< 1% O2) conditions for 6-48 h.  HIF1α expression levels at 12 
h (Clone 2) and 24 and 48 h (TRF) respond to Rosi and are absent in Pparg-null TSCs.  NDRG1 expression is elevated 
in the absence of PPARγ in normoxic trophoblasts.  β-actin confirms equal sample loading in all lanes. 
 
Rosi (lanes 9, 24, 26) consistent with our earlier interpretation that the extent of PPARγ activation 
correlates positively with the extent of sustained HIF1α expression.  PPARγ protein expression 
declined by 12 h post hypoxic exposure in both WT lines (lanes 8-13, 21-26).  This decline in 
PPARγ protein was accompanied by a rise in NDRG1 levels by 12 h in hypoxia (lanes 8, 21), 
whereas treatment with Rosi mitigated this increase (lanes 9, 11).  Here too, Muc1 expression 
declined over time in hypoxia.   
In Pparg-null TSCs, HIF1α was strongly induced by 6 h post hypoxia in Pparg-null TSCs 
(lanes 4, 17), yet rapidly declined by 12 h (lanes 7, 20).  By 24 h cell death was near-complete, 
precluding protein analysis.  The inverse relationship between PPARγ and NDRG1 was evident in 
GY20 as well.  The absence of PPARγ enhanced NDRG1 expression at baseline (lanes 1, 14) and 
augmented NDRG1 levels in hypoxia relative to WT (lanes 4, 7, 17, 20), consistent with results 
shown in Figure 1.  This confirms that PPARγ plays a role in the negative regulation of NDRG1.   
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It is worthwhile to point out that while PPARγ and HIF1α protein decay kinetics in both 
WT clones were accelerated compared to the clone GY11 counterpart, the requirement of PPARγ, 
the positive effect of Rosi, and the overall trend of NDRG1 remained the same.  All further 
experiments were carried out with GY 11 (WT) and GY9 (Pparg-null) as these clones were 
consistent and robust in the expression of key proteins of interest. 
3.1.1.2 The influence of oxygen  
Early in gestation, the hypoxic uterine environment facilitates placentation by promoting 
trophoblast proliferation and providing the necessary stimulus for fetal vessel angiogenesis 
(Adelman DM et al., 2000).  Once the labyrinthine vascular tree is fully established, blood that 
flows through the feto-placental unit contains ~8.6% oxygen in humans (Rodesch F et al., 1992).  
Culture of TSCs under “standard” tissue culture conditions, i.e., ambient air or 21% oxygen, 
therefore represents hyper-oxic conditions and may not be representative of the in vivo baseline 
expression of key hypoxia-regulated proteins.   
To ensure validation of the established model, WT TSCs were cultured under standard 
tissue culture conditions or 8% oxygen for 24 and 48 h.  PPARγ expression did not change with 
respect to oxygen saturation, hypoxia duration, or ligand stimulation (Figure 3).  Importantly, 
PPARγ levels were similar at 21% and 8% oxygen and did not decline under reduced oxygen 
conditions, as seen in Figures 1 and 2.  It was concluded that TSCs cultured under physiologically 
relevant versus standard conditions did not influence baseline expression of PPARγ protein.  All 
normoxic conditions in subsequent studies were carried out in 21% oxygen for convenience and 
simplicity.    
The emerging relationship between placental PPARγ and HIF1α during acute oxygen deprivation 
raised the question whether artificial HIF1α stabilization in normoxia would mimic the effect and 
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provide insight into the regulation of key hypoxia-responsive proteins.  Cobalt chloride (CoCl2), a 
transition metal salt and PHD inhibitor, was used to manipulate HIF1α levels in vivo.  PHD2 is a 
non-heme requiring enzyme and, in the presence of oxygen, catalyzes hydroxylation of proline 
residues in the ODD of HIF.  These hydroxyprolines function as docking sites for VHL, which 
recruits an E3 ligase that targets HIF for polyubiquitination and subsequent proteasomal 
degradation (Maxwell PH et al., 1999).  CoCl2 is a competitive inhibitor of iron and prevents the 
interaction between PHD2 and the ODD of HIF1α by occupying an iron-binding site on PDH2, 
thus preventing HIF degradation in the presence of oxygen (Epstein AC et al., 2001).   
 
 
Figure 3-3- 8% oxygen does not alter PPARγ levels. 
WT TSCs (GY11) were differentiated for 3 days and cultured under 21% or 8% O2 for an additional 24 and 48 h in 
the presence or absence of Rosi (1 µM).  The expression of PPARγ in TSCs reared 8% O2 does not change relative to 
control. 
 
Initially, WT and Pparg-null TSCs were incubated with varying concentrations of CoCl2 
for 24 h to determine a suitable working range (Figure 4A).  HIF1α levels increased in a dose-
dependent manner in WT and Pparg-null TSCs (lanes 1-10).  In contrast, PPARγ protein levels 
were unchanged (lanes 1-5).  NDRG1 was increased in WT cells only in the presence of >200µM 
CoCl2 a dose-dependent manner in WT cells (lanes 4,5), yet was consistently elevated in Pparg-
null TSCs irrespective of CoCl2 concentration (lanes 6-10).  Because 200 µM CoCl2 was sufficient 
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for maximal HIF1α stabilization both in WT and Pparg-null TSCs and NDRG1 activation in WT 
TSCs, this concentration was subsequently used to investigate the expression kinetics pattern of 
hypoxia-regulatory proteins of interest.  In Figure 4B, WT and Pparg-null TSCs were incubated 
with 200µM CoCl2 for 6-48 h in the presence or absence of Rosi.  HIF1α levels remained stable 
up to 48 h in both WT TSCs and Pparg-null TSCs and did not respond to Rosi.  Similarily, the 
expression of PPARγ in WT TSCs was relatively unchanged over time and upon ligand 
stimulation.  Collectively, these data indicate that PPARγ and HIF1α induction and decay patterns 
are driven by the complex effect of oxygen deprivation, and cannot be mimicked simply by CoCl2-
mediated HIF1α stabilization.  Therefore, CoCl2 treatment is an unsuitable replacement for oxygen 
deprivation in this system.  
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Figure 3-4- Cobalt chloride does not mimic the effect of oxygen deprivation in TSCs. 
WT (GY11) or Pparg-null TSCs were differentiated for 3 days and (A) incubated with varying concentrations of 
CoCl22 for 24 h or (B) incubated with CoCl2 (200 µM) for 6-48 h in the presence or absence of Rosi (1 µM).  (A) 
HIF1α and NDRG1 levels increased in a dose-dependent manner in WT TSCs, but PPARγ levels were unchanged.  
NDRG1 levels were elevated in Pparg-null TSCs as compared to WT irrespective of CoCl2 concentration.  (B) PPARγ 
and HIF1α levels were unchanged over the course of CoCl2 exposure in both WT and null cell lines.   
3.1.2 PPARγ-NDRG1 regulation occurs at the RNA level 
The requirement of PPARγ to sustain HIF1α protein levels (Figures 1 and 2) in hypoxic 
TSCs prompted a search for the potential mechanism.  Because PPARγ is a TF, regulation at the 
gene level was a logical starting point.  WT and Pparg-null TSCs were cultured under standard or 
hypoxic conditions and the temporal expression patterns of key hypoxia-responsive transcripts 
were analyzed (Figure 5).  
Hif1a mRNA levels steadily declined over time and plateaued by 12 h in both hypoxic WT 
and Pparg-null TSCs.  All Pparg-null TSCs had died by 24 h in hypoxia, obviating gene 
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expression analysis.  The addition of Rosi had no effect on Hif1a mRNA at any time point in WT 
TSCs.  These findings are consistent with previous reports that HIF1α regulation primarily occurs 
post-translationally (Koh MY et al., 2012).    
 Conversely, Pparg transcripts in WT TSCs increased by 6 h in hypoxia, declined to near 
baseline levels by 12 h, and plateaued thereafter.  The overall trend indicates that the increase in 
PPARγ protein in the early stages of hypoxia (Figure 1C, lane 2) may be regulated at the 
transcriptional level, whereas its later decline may occur, at least in part, at the post-transcriptional 
level.  Pparg levels steadily declined in WT TSCs stimulated with Rosi, as shown previously at 
the protein level (Figure 1A), consistent with a putative negative feedback loop (Shalom-Barak T 
et al., 2004; 2012). Pparg expression was undetected in null TSCs as expected.   
Importantly, the data revealed that NDRG1 regulation by placental PPARγ occurs 
primarily at the transcriptional level.  The baseline expression of Ndrg1 was higher in normoxic 
Pparg-null TSCs relative to WT, although more power would be required for statistical 
significance.  Ndrg1 levels steadily rose in hypoxic Pparg-null TSCs and peaked at 12 h, the last 
time point at which samples could be collected.  Ndrg1 levels also increased in hypoxic WT TSCs, 
albeit to a lesser degree, and the addition of Rosi mitigated the increase at 6 and 12 in hypoxia.  
By 24 h hypoxic exposure Ndrg1 expression in WT TSCs began to decline and converge with WT 
TSCs treated with Rosi.  Whereas protein levels of NDRG1 in WT TSCs steadily increased over 
time in hypoxia (Figures 1 and 2) transcriptional upregulation appeared to cease at 12 h, suggesting 
a potential switch to post-translational regulation during chronic hypoxic exposure.       
Muc1, the most robust target of placental PPARγ (Shalom-Barak T et al., 2004; 2012), 
followed “bowl-shaped” expression kinetics over the course of hypoxic treatment in both WT and 
Pparg-null TSCs.  Muc1 mRNA levels steadily declined, bottomed out at 12 h, and slightly 
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recovered by 24 h in hypoxia.  The expression of Muc1 remained highest in WT TSCs treated with 
Rosi.  Unsurprisingly, Muc1 transcript levels were substantially lower in Pparg-null TSCs, as 
previously reported (Shalom-Barak T et al., 2004; 2012).  The overall timeline of Muc1 decay in 
hypoxic Pparg-null TSCs was accelerated, yet still recapitulated the overall trend.  Every time 
point analyzed had varying degrees of statistical significance, except WT TSCs  Rosi at 24 h, yet 
were excluded from the figure for the sake of clarity.  Although the exact role of Muc1 in the 
placenta is yet to be defined, it is tempting to speculate a possible role in the hypoxic signaling of 
trophoblasts, especially in light of recent reports to this effect in other cell types (Pastor-Soler NM 
et al., 2015; Shukla SK et al., 2017). 
 
 
Figure 3-5- PPARγ negatively regulates NDRG1 transcription 
Expression of four hypoxia-regulated genes in WT (GY11; solid lines, squares) and Pparg-null (GY9; solid lines, 
triangles) TSCs over the course of acute oxygen deprivation in the absence (open squares) or presence (filled squares, 
dashed lines) of 1 µM Rosi.  Each qPCR measurement was performed in duplicate, normalized to the Dazap1 gene, 
and analyzed with the ΔΔCT method.  Expression under standard tissue culture conditions in the absence of Rosi was 
assigned a relative value of 1.0.  Values were analyzed with a one-way ANOVA and Tukey’s post hoc test.  P < 0.05 
was considered significant.  Error bars designate sd.  NDRG1 RNA is elevated in the absence of Pparg.    
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3.2 A new role for lactate? 
In the absence of direct transcriptional regulation of HIF1α  by PPARγ, the focus of this 
thesis shifted back to the known targets of placental PPARγ.  PPARγ regulates multiple metabolic 
enzymes in the mouse placenta, with two of the strongest targets being LDHB and PCX (Shalom-
Barak T et al., 2012).  LDHB is responsible for converting lactate to pyruvate, and PCX converts 
the pyruvate product of LDHB to OAA, a pleiotropic intermediate that replenishes numerous 
metabolic pathways (Takeno T et al., 1998; Jitrapakdee S et al., 1999).  Given the intimate 
association of lactate production and oxygen deprivation, the idea that PPARγ and its 
transcriptional targets modulate the expression of key hypoxia-regulated proteins via lactate 
metabolism began to form.  This chapter explores the role of lactate and its metabolites in the 
hypoxic signaling of trophoblasts. 
3.2.1 Pparg-null TSCs accumulate lactate in hypoxic conditions 
Non-targeted metabolomics were used to characterize the intracellular metabolite pools of 
WT and Pparg-null TSCs reared in standard and acute hypoxic conditions for 12 h (Figure 6).  The 
greatest differential between HIF1α protein expression in WT and Pparg-null TSCs was observed 
at the 12th h of hypoxic exposure (Figures 1 and 2), and therefore, was chosen for interrogation.  
In WT TSCs, intracellular pyruvate concentrations were relatively unchanged after 12 h of 
hypoxic exposure compared to normoxia.  In contrast, while the intracellular pyruvate of normoxic 
Pparg-null TSCs were below the detection threshold, they increased dramatically in hypoxia, 
although fell short of attaining statistical significance due to wide data distribution. 
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Similar to pyruvate, 12 h of hypoxic treatment did not alter intracellular lactate 
concentrations in WT TSCs.  However, intracellular lactate significantly accumulated in hypoxic 
relative to normoxic Pparg-null TSCs.  Pparg-null TSCs also accumulated more intracellular 
lactate by 12 h in hypoxia compared to WT TSCs.  These data demonstrate a central role for 
PPARγ and by proxy, its target genes, in trophoblast lactate clearance, under acute hypoxic 
conditions.    
 
 
Figure 3-6- Pparg-null TSCs accumulate lactate in hypoxia 
WT (GY11; open circles) and Pparg-null (GY9; closed circles) TSCs were cultured under hypoxic conditions for 12 
h.  Metabolism was immediately quenched by the addition of ice-cold 80% MeOH.  Samples were sent to the 
University of Minnesota for untargeted aqueous phase metabolomic analysis.  Values were analyzed using a two-way 
ANOVA and Tukey’s multiple comparisons test.  P < 0.05 was considered significant.  ND = not determined.  Pparg-
null TSCs accumulate significantly more lactate in hypoxia than the WT counterparts.      
 
3.2.2 The regulatory properties of lactate 
The differential accumulation of intracellular metabolites in WT versus Pparg-null 
hypoxic TSCs further supported the burgeoning concept that PPARγ-mediated regulation of 
HIF1α and additional hypoxia-responsive proteins occurs at the level of lactate metabolism.  JEG-
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3 cells, a transformed human choriocarcinoma cell line, were used to interrogate the effects of 
intracellular lactate manipulation on the expression of key hypoxia-regulated proteins.  First, JEG-
3 cells were incubated with varying concentrations of exogenous L-lactate for 24 h under standard 
tissue culture conditions (Figure 7A).  The highest concentration of L-lactate (100 mM) increased 
the levels of HIF1α, PPARγ, and NDRG1 proteins in normoxia (7A lane 4), suggesting that all 
three could be stabilized by excess cellular lactate, perhaps through a joint mechanism.      
Inhibitors of lactate metabolism were used in parallel to compare the expression profiles 
of key hypoxia-regulatory proteins.  JEG-3 cells were cultured under hypoxic conditions for 24 h  
 
 
Figure 3-7 - Lactate alters the expression of hypoxia-regulated proteins 
JEG-3 cells were cultured under standard (A) or hypoxic (B) conditions for 24 h in the presence or absence of various 
inhibitors +/– exogenous L-lactate. (A) Exogenous L-lactate positively regulates PPARγ, HIF1α, and NDRG1 under 
standard conditions; + - 25 mM, ++ - 50 mM, +++ - 100 mM. (B) PPARγ, HIF1α, and NDRG1 are negatively regulated 
by the LDH inhibitor oxamate (Ox); + - 50 mM lactate, 1 µM AR – AR-C155858 (MCT1/2 inhibitor;), Ox – 10 or 40 
mM sodium oxamate (LDH inhibitor). β-actin confirms equal sample loading in all lanes. 
 
in the presence or absence of various inhibitors of lactate metabolism  50 mM exogenous 
L-lactate (Figure 7B).  HIF1α and NDRG1 protein were absent in normoxia (7B lane 1) and 
increased under acute hypoxic conditions (7B lane 2) as predicted.  PPARγ protein levels were 
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relatively stable in hypoxia (7B lane 2) in contrast to WT TSCs (Figures 1 and 2).  The expression 
of hypoxia-regulated proteins were unchanged with the addition of exogenous L-lactate or 
inhibition of lactate flux into the cell via MCT1/2 inhibitor AR-C15585 (AR) (7B lanes 3, 4).  
MCT1 is a high-affinity monocarboxylate transporter located on the basal plasma membrane of 
SynTs (fetal-facing) in the human term placenta and drives lactate into the cell (Nagi A et al., 
2010; Settle P et al., 2004).  Therefore, the addition of lactate or inhibition of transport into the 
cell did not alter the expression of hypoxia-responsive proteins. 
Expression levels of HIF1α, PPARγ, and NDRG1 drastically declined in JEG-3 cells 
treated with the pan-LDH inhibitor sodium oxamate (Ox; 10 mM) (7B lane 5), and addition of 
exogenous L-lactate augmented the effect (7B lane 6).  Levels of HIF1α, PPARγ, and NDRG1 
protein were almost completely diminished in JEG-3 cells treated with 40 mM Ox (7B lane 7).  
JEG-3 cells treated with 40 mM Ox and supplemented with 50 mM exogenous L-lactate all died, 
precluding protein analysis.  
Importantly, JEG-3 are cancerous by nature and thus may not accurately represent the 
hypoxic response of native trophoblasts.  To further validate the findings in JEG-3 cells, WT TSCs 
were cultured under hypoxic conditions for 24 h in the presence or absence of various inhibitors 
of lactate metabolism  50 mM exogenous L-lactate (Figure 8).  HIF1α, PPARγ, and NDRG1 were 
expressed by 24 h in hypoxia (lane 1).  Neither the addition of exogenous L-lactate or treatment 
with the MCT1/2 inhibitor AR had an effect on the expression of hypoxia-responsive proteins 
(lanes 2, 3).  Treatment with 10 mM Ox slightly attenuated HIF1α protein levels (lane 4) and this 
effect was mitigated with the addition of exogenous lactate (lane 5).  In contrast, treatment with 
40 mM Ox significantly decreased HIF1α protein levels (lane 6) and addition of lactate synergized 
 42 
 to further diminish HIF1α levels (lane 7).  Overall PPARγ expression levels did not 
significantly change with inhibitor treatment (lanes 1-6).  Although it is worthwhile to note that 
40 mM, but not 10 mM, Ox significantly decreased PPARγ protein (lane 6).  This effect was further 
augmented in the presence of exogenous L-lactate (lane 7).  The response of NDRG1 to chemical 
inhibitors or exogenous lactate was much weaker than HIF1α or PPARγ.  NDRG1 levels were 
slightly increased in response to 10 mM Ox (lane 4) and ameliorated by the addition of lactate 
(lane 5).  The significance of this response is not clear at this time.  Overall, these data suggest that 
the manipulation of intracellular lactate concentrations may have the same effect in both TSCs and 
JEG-3 cells, albeit with different sensitivity thresholds.     
 
 
Figure 3-8- Response of TSCs to intracellular lactate modification 
WT TSCs (GY11) were differentiated for 3 days and cultured under hypoxic conditions for 24 h in the presence or 
absence of various inhibitors of lactate metabolism +/– exogenous L-Lactate.  PPAγ and HIF1α are negatively 
regulated by the LDH inhibitor Ox; + - 50 mM lactate, AR – 1 µM, Ox – 10 or 40 mM.  β-actin confirms equal sample 
loading in all lanes. 
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3.2.2.1 Responses of hypoxia regulators to LDH inhibition 
The differential regulation of hypoxia-responsive proteins to low (10 mM) and high (40 
mM) Ox concentrations (Figure 7 and 8) was striking and warranted further investigation.  The 
effects of Ox at three different concentrations – 10, 20, and 40 mM – was used to further define 
the dynamic regulation of hypoxia-responsive protein inhibition.  JEG-3 cells were cultured under 
standard or hypoxic conditions from 6-48 in the presence or absence of varying concentrations of 
Ox.  By 48 h in hypoxia untreated JEG-3 cells, as well as JEG-3 cells treated with 20 or 40 mM 
Ox, had died, obviating protein analysis (Figure 9).  In contrast, JEG-3 cells treated with 10 mM 
Ox survived up to 48 h in hypoxia, suggesting that minor manipulations of the intracellular lactate 
pool translate to large scale effects ranging from variable protein expression to decreased cell 
viability. 
As expected, HIF1α protein levels steadily increased in untreated WT cells (lanes 1-4) as 
predicted.  Treatment with 10 mM Ox augmented protein levels of HIF1α at 24 and 48 h in hypoxia 
relative to control (lanes 4-9).  In stark contrast, expression of HIF1α was significantly decreased 
by 6 h post hypoxia in cells treated with 20 mM Ox (lane 10).  HIF1α levels were further reduced 
to near zero by 12 h (lane 11) and completely diminished by 24 h in hypoxia (lane 12).  The 
increase of Ox concentration from 20 mM to 40 mM was sufficient to cease HIF1α induction all 
together (lanes 14-17).  It’s tempting to speculate that the decline of HIF1α levels (lanes 11, 12, 
14-17) in cells treated with 20 mM and 40 mM contributed, to or directly caused, lethality.    
PPARγ levels were stable throughout the course of hypoxia in untreated JEG-3 cells (lanes 
1-4).  Cells treated with 10 mM Ox increased PPARγ expression in normoxia (lane 5) relative to 
untreated WT cells.  PPARγ expression peaked at 6 h, remained elevated by 24 h, and decreased 
by 48 h in hypoxia compared to untreated JEG-3 cells in acute hypoxic conditions (lanes 5-9).  
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Treatment with 20 and 40 mM Ox induced a similar, albeit accentuated, trend with PPARγ levels 
peaking at 6 h (lanes 11, 15), declining by 12 h (lanes 12, 16), and completely abolished by the 
24th h of hypoxic exposure (lanes 13, 17). 
 
 
Figure 3-9- Refined analyses of the effects of lactate metabolism inhibitors 
JEG-3 cells were treated with increasing concentrations of the LDH inhibitor Ox and culture in standard or hypoxic 
conditions for 6-48 h.  Low [Ox] and high [Ox] exhibit unique effects on hypoxia-regulated proteins, suggesting 
differentiational LDH isozyme inhibition. 
 
 
NDRG1 protein behaved as expected in untreated JEG-3 cells.  NDRG1 levels were absent 
under standard tissue culture conditions (lane 1), increased by 12 h, and were sustained out to 24 
h in hypoxia (lanes 3, 4).  Unlike HIF1α and PPARγ, NDRG1 followed a similar expression pattern 
in cells treated with 10 mM and 20 mM Ox.  Peak NDRG1 levels were observed at 12 h (lanes 7, 
12) and declined to near zero by 24 h in hypoxia (lanes 8, 13).  Interestingly, NDRG1 expression 
levels were slightly rescued by 48 h in hypoxia in JEG-3 cells treated with 10 mM Ox (lane 9).  
Treatment of cells with 40 mM Ox increased the NDRG1 induction timeline, with peak levels 
observed at 6 h in hypoxia (lane 15).  Elevated expression levels were sustained at 12 h (lane 16) 
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and completely eradicated by 24 h (lane 17) in post-hypoxic exposure.  Taken together, these data 
suggest that lactate metabolism, whether its rate of clearance or degradation to metabolic by 
products, has a distinctive quantitative and qualitative effect on the response of hypoxia-regulated 
proteins that warranted further investigation.   
3.2.3 Lactate measurements and subsequent in vitro response 
Previous data indicated that the regulation of lactate metabolism has a profound inhibitory 
role on key hypoxia-responsive proteins (Figures 7-9), yet the actual intracellular lactate 
concentrations in response to pharmacological manipulations were unclear.  Importantly the pan-
LDH inhibitor Ox suppresses the activity of both LHDA (lactate generation) and LDHB (lactate 
clearance).  The dual-action inhibitory properties obscure true effects on the intracellular lactate 
milieu.  To that end, key nodes of the experiment were repeated by culturing JEG-3 cells under 
either standard or hypoxic conditions for 6-12 h in the presence exogenous lactate, Ox, the PCX 
inhibitor phenylacetic acid (PA; 2.5 mM), and collecting parallel samples for either Western blot 
or intracellular lactate measurements. 
Figure 10A demonstrates that while PPARγ levels remained relatively stable when cultured 
under standard or hypoxic conditions for 6-12 h, the levels of HIF1α protein drastically increased 
and NDRG1 levels slightly increased in response to the hypoxic stimulus (lanes 1-4).  In contrast, 
the addition of 50 mM lactate in normoxia dramatically down-regulated PPARγ protein expression 
within 12 h (lane 6).  The decline in PPAγ levels was accompanied by a significant increase in 
intracellular lactate accumulation (P = 0.0004) relative to untreated normoxic controls (Figure 
10B).  Paradoxically, PPARγ protein levels remained unchanged in hypoxic TSCs treated with 
exogenous lactate (lanes 7, 8).  A possible interpretation of this observation is that unscheduled 
 46 
lactate accumulation, in a manner that is not coordinated with oxygen deprivation and HIF1α 
pathway activation, suppresses PPARγ expression.  Consistent with the earlier data (Figure 9), 
treatment of JEG-3 cells with 10 mM Ox did not influence the expression of PPARγ (10A lanes 9, 
10), whereas 40 mM Ox near-completely abolished PPARγ levels by 12 h in hypoxia (lanes 11, 
12).  Importantly, intracellular lactate concentrations were decreased to a similar extent in JEG-3 
cells cultured in the presence of either 10 mM or 40 mM Ox (Figure 10C).  PPARγ expression was 
also negatively regulated by PA at 12 h post hypoxic exposure (lane 14).  PA is metabolized in 
vivo into phenylacetyl CoA, a structural analog of acetyl CoA, and inhibits the enzymatic activity 
of PCX in an allosteric fashion (Zeczycki TN et al., 2010).  PCX inhibition would cause a buildup 
of intracellular pyruvate, which allosterically activates LDHA and results in lactate production.  
Indeed, the addition of PA in hypoxia slightly increased the intracellular lactate levels, albeit not 
to a statistically significant manner (Figure 10C).  These observed effects were largely 
recapitulated in WT mouse TSCs (Figure 10D), with two minor exceptions. First, in lactate-treated 
normoxic TSC cultures, PPARγ levels did not decline (lane 6).  Second, 40 mM Ox resulted in 
PPARγ down-regulation as early as 6, rather than 12 h after hypoxic exposure.  
HIF1α levels were not present JEG-3 reared under standard tissue culture conditions 
(Figure 10A lanes 1, 2, 5 6), and robustly induced by 6 h in hypoxia (lane 3).  The addition of 
exogenous L-lactate reduced HIF1α levels by 6 h in hypoxia, and levels remained low at 12 h post-
hypoxic exposure (lanes 7, 8).  The addition of both 10 mM and 40 mM Ox completely diminished  
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Figure 3-10- Intracellular lactate measurements and accompanying in vitro protein 
JEG-3 cells (A) or WT TSCs (GY11; D) were cultured under standard or hypoxic conditions for 6-12 h in the presence 
or absence of exogenous L-lactate or inhibitors of lactate metabolism.  Exogenous L-lactate – 50 mM; Low [Ox] – 10 
mM; High [Ox] – 40 mM. Phenylacetic acid (PA – phenylacetic acid; 2.5 mM).  (A) and (D) 40 mM Ox abolished 
HIF1α and PPARγ levels at both hypoxic time points.  (B-C) JEG-3 cells were cultured as described and collected for 
intracellular [lactate] analysis.  Briefly, samples were scraped in ice-cold 8% perchloric acid to quench metabolic 
processes and neutralized.  Undiluted samples were analyzed using the Amplite Fluorimetric assay kit exactly 
according to manufacturer’s instructions. Values were analyzed with two-way ANOVA and Tukey’s multiple 
comparisons test.  Some significance designations were omitted for clarity and exclusively stated in the text.  P < 0.05 
was considered significant.        
 
HIF1α expression at all time points analyzed in hypoxic JEG-3 cells (lanes 9-12), consistent with 
results in Figure 9 (lanes 6, 7, 15, 16).  This inconsistency may be the function of different culture 
conditions or cellular density.  PA administration also reduced HIF1α levels at both 6 and 12 h of 
hypoxic exposure relative to untreated hypoxic cells (10A lanes 13, 14). Combined, these data 
provide a correlation that the intracellular lactate pool largely influences the expression of hypoxia-
regulated proteins. 
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Unlike JEG-3 cells, in TSCs, addition of exogenous lactate, 10 mM Ox, or PA had no 
discernable effect on HIF1α levels at the 6th or 12th h of hypoxic exposure (Figure 10D, lanes 7-
10, 13-14).   However, similar to JEG-3 cells, HIF1α levels were decreased at both 6 and 12 h of 
hypoxia in the presence of 40 mM Ox (10D lanes 11-12).  The basis for these differential effects 
of lactate metabolism inhibitors in TSCs versus JEG-3 cells could be attributable to the 
transformed nature of JEG-3 cells or the multi-lineage nature of differentiated TSC. 
While NDRG1 levels were relatively unchanged at all time points analyzed, it is 
worthwhile to note that NDRG1 protein was present in normoxic JEG-3 cells in the absence of 
inhibitor treatment (10A lanes 1, 2).  This discrepancy was unexpected, and may be a function of 
either culture density or the cancerous nature of JEG-3 cells and their altered metabolism.  
Treatment with PA completely eradicated NDRG1 levels by 12 h in hypoxia (10A lane 14).  
Whereas NDRG1 expression was relatively stable in JEG-3 cells irrespective of oxygen saturation, 
NDRG1 levels were increased in hypoxic TSCs by 12 h (10D lane 4).  The addition of exogenous 
lactate further increased levels at both 6 and 12 h in hypoxia (10D lanes 7, 8), an effect not observed 
in JEG-3 cells.  The addition of 10 mM Ox had no effect on NDRG1 expression (10D lanes 9, 10) 
although treatment with 40 mM Ox and PA significantly reduced NDRG1 protein (10D lanes 11-
14). 
Overall, the stochastic relationships between the effects of lactate and the various lactate 
metabolism inhibitors on intracellular lactate concentrations and levels of hypoxia-regulated 
proteins suggest that another downstream metabolite, or potentially a lactate derivative, rather than 
lactate itself, regulates hypoxic signaling in trophoblasts. 
The results from Figure 10B show that, surprisingly, intracellular lactate levels in JEG-3 
cells do not increase by 12 h in hypoxia.  Therefore, the time frame was extended, and JEG-3 cells 
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were cultured under hypoxic conditions for 24h.  Intracellular lactate levels increased slightly 
(Figure 11), although not to statistical significance, possibly attributable to one outlier.  The 
response of hypoxia-regulated proteins, and accompanying intracellular lactate levels, to 
pharmacological inhibitors were further analyzed to investigate the effect of sustained hypoxic 
insult (Figure 12).  JEG-3 cells were cultured under standard or hypoxic conditions for 24 h in the 
presence or absence of lactate metabolism inhibitors  exogenous lactate.  The addition of 
exogenous lactate in all conditions analyzed significantly increased intracellular lactate levels 
irrespective of pharmacological manipulation (Figure 12B). 
 
 
Figure 3-11 - Intracellular lactate concentrations in normoxic and hypoxic JEG-3 cells 
Intracellular lactate levels were measured in JEG-3 cells cultured under standard or hypoxic conditions for 24 h.  
Values were analyzed with an unpaired t-test and Welch’s correction.  P < 0.05 was considered significant.  Culture 
of JEG-3 cells under hypoxic conditions did not increase intracellular lactate accumulation.   
 
The expression levels of PPARγ protein were relatively unchanged in response to 
stimulation with various inhibitors under normoxic conditions (Figure 12A), although treatment 
with 100 mM lactate decreased PPARγ protein (12A lane 2) consistent with results in figure 10A.  
In fact, the addition of 50 mM exogenous lactate was sufficient to decrease PPARγ protein in all 
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normoxic treatment groups, irrespective of inhibitor treatment (12A lanes 4, 6, 8, 10).  PPARγ 
levels decreased by 24 h in hypoxia, but this effect could be mitigated with the addition of lactate 
(12A lanes 11, 12).  The addition of 10 mM Ox increased the expression of PPARγ in hypoxic 
JEG-3 cells, consistent with results in Figure 9 (Figure 9 lane 8), while the addition of 10 mM Ox 
and exogenous lactate was sufficient to completely abolish expression (12A lanes 13, 14).  The 
combinatorial effects of 10 mM Ox and 50 mM lactate increased intracellular lactate levels above 
baseline in hypoxia (Figure 12B), yet levels remained lower than with the addition of 50 mM 
lactate alone, as previously reported (Figures 7, 9, 10).  
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Figure 3-12- Protein and intracellular lactate response to sustained hypoxic insult 
JEG-3 cells were cultured under standard or hypoxic conditions for 24 h in the presence or absence of exogenous L-
lactate or inhibitors of lactate metabolism.  Exogenous L-lactate + - 50 mM or ++ - 100 mM; Low [Ox] – 10 mM; 
High [Ox] – 40 mM. PA – 2.5 mM; FX11 – LDHA inhibitor – 10 µM.  (A) 40 mM Ox abolished HIF1α and PPARγ 
levels, similar to results shown in Figure 10A.  (B) JEG-3 cells were cultured as described and collected for 
intracellular [lactate] analysis.  Values were analyzed with one-way ANOVA and Dunnett’s multiple comparisons 
test.  P < 0.05 was considered significant.  All significance designations (*) are relative to baseline control. The 
addition of exogenous L-lactate increased intracellular levels in both normoxic and hypoxic conditions irrespective of 
inhibitor treatment.        
 
The addition of 40 mM Ox and 50 mM lactate was sufficient to cause lethality, precluding protein 
analysis.  The absence of PPARγ in JEG-3 cells treated with 40 mM Ox was coincident was a 
significant decrease in intracellular lactate levels (Figure 13A), indicating that ultra-precise 
regulation of lactate metabolism under conditions of acute hypoxia is required for the expression 
of PPARγ (Figure 12B and 13A).  Treatment of JEG-3 cells with FX11 (FX), a selective, 
reversible, NADH competitive inhibitor of LDHA, did not result in a decline of intracellular lactate 
 52 
levels in hypoxic JEG-3 cells (Figure 13B), and PPARγ expression was maintained (Figure 12A 
lane 16).   Treatment of hypoxic JEG-3 cells with PA, irrespective of exogenous lactate, decreased 
PPARγ protein levels (12A lanes 18, 19).  The addition of PA alone had no effect on intracellular 
lactate levels in hypoxia, while the combination of PA and exogenous lactate increased 
intracellular lactate accumulation (Figure 13C).        
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Figure 3-13- Effect of pharmacological inhibitors on intracellular lactate levels 
JEG-3 cells were cultured under standard or hypoxic conditions for 24 h in the presence or absence of exogenous L-
lactate or inhibitors of lactate metabolism and collected for intracellular [lactate] analysis..  Exogenous L-lactate - 50 
mM; Low [Ox] – 10 mM; High [Ox] – 40 mM. PA – 2.5 mM; FX11 – 10 µM.    Values were analyzed with a two-
way ANOVA and Tukey’s multiple comparisons test.  P < 0.05 was considered significant.  Inhibitors had varying 
effects on intracellular lactate accumulation. 
 
HIF1α protein levels were largely absent in normoxic JEG-3 cells (Figure 12A) yet levels 
were increased when treated with either FX and PA in the absence of exogenous lactate (12A lanes 
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7 and 9).  Intracellular lactate levels were slightly increased in normoxic cells treated with FX and 
PA (Figure 13B and C), potentially contributing to HIF1α accumulation in standard conditions.  
Singlet HIF1α protein is increased by 24 h in hypoxia as expected (12A lane 11).  HIF1α levels 
were further increased with the addition of 50 mM exogenous lactate (12A lane 12) and 10 mM 
Ox (12A lane 13).  Importantly, HIF1α levels were sustained in the presence or absence of high 
intracellular lactate concentrations (Figure 12B), indicating that additional regulation, either at the 
metabolite or protein level, is involved in maintaining HIF1α levels in hypoxia.  Treatment of 
hypoxic JEG-3 cells with 10 mM Ox and exogenous lactate, or 40 mM Ox alone, completely 
abolished HIF1α protein levels (Figure 12A lanes 14, 15).  In contrast, HIF1α levels were 
unchanged with the addition of FX irrespective of lactate supplementation (12A lanes 16, 17).  
Treatment with FX decreased lactate levels similar to that of 10 mM and 40 mM Ox (Figure 12B), 
further contributing to the notion that additional regulation of hypoxia-responsive proteins is at 
play.  Singlet HIF1α protein was observed in JEG-3 cells treated with PA (12A lane 18) and the 
addition of lactate rescued the HIF1α doublet (12A lane 19).  These data indicate that intracellular 
lactate, under normoxic conditions, can stabilize HIF1α, although the intimate details of this 
complex regulation, particularly under hypoxic conditions, remains elusive.  
NDRG1 protein levels were remained at near zero in most normoxic conditions yet were 
slightly induced when cultured with the highest concentration of Ox and exogenous lactate (12A 
lane 6).  Curiously, the addition of exogenous lactate alone (12A lane 2) was insufficient to 
increase NDRG1 levels despite higher intracellular lactate concentrations (Figure 12B).  
Additionally, treatment of normoxic JEG-3 cells with FX or PA, in the presence or absence of 
lactate, increased NDGR1 levels (12A lanes 7-10) despite drastically different intracellular lactate 
levels (Figure 13B, C).  Robust NDRG1 induction was observed by 24 h in hypoxia (12A lane 11) 
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and sustained with the addition of 50 mM lactate (12A lane 12).  The addition of 10 mM Ox 
decreased intracellular lactate levels in hypoxia (Figure 13A) and a coincident decline in NDRG1 
protein level was observed (Figure 12A lane 13), consistent with results from Figure 9 lane 8.  
However, the addition of exogenous lactate was unable to ameliorate this decline (12A lane 14) 
despite increased intracellular lactate levels (Figure 12B).  Treatment of hypoxic JEG-3 cells with 
40 mM Ox caused a similar decline in NDRG1 protein (12A lane 15) and coincided with 
significant decrease in intracellular lactate levels relative to 10 mM Ox (Figure 13B).  NDRG1 
levels were relatively stable with the addition of FX or PA, irrespective of lactate supplementation, 
in hypoxia (12A lanes 16-19).       
The expression of Muc1 in the presence or absence of various inhibitors of lactate 
metabolism was investigated to determine if intracellular lactate manipulation could sustain Muc1 
levels in hypoxia (see Figures 1 and 2).  Baseline normoxic expression of MUC1 was not observed 
in JEG-3 cells (Figure 12A lanes 1-10), potentially owing to their predominately hypertriploid or 
cancerous nature.  Muc1 protein levels were significantly induced with 50 mM lactate 
supplementation by 24 h in hypoxia (12A lane 12).  The addition of 10 mM Ox in hypoxia did not 
result in a significant decline in intracellular lactate production as compared to hypoxic controls 
(Figure 13A), yet was sufficient to cause a reduction in Muc1 protein levels (12A lane 13).  The 
addition of exogenous lactate completely abolished protein levels, consistent with the regulation 
of additional hypoxia-responsive proteins (12A lane 14), and resulted in a significant increase of 
lactate accumulation relative to hypoxic controls (Figure 12B).  Moreover, treatment with 40 mM 
Ox resulted in a complete shutdown of Muc1 protein, consistent with the levels of PPARγ and 
HIF1α (12A lane 15).  This effect was recapitulated in hypoxic JEG-3 cells treated with FX (12A 
lane 16).  Interestingly, both inhibitors reduced lactate levels as compared to hypoxic controls 
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(Figure 12B), yet were largely similar to the lactate concentration in hypoxic cells treated with 10 
mM Ox, which permitted Muc1 expression (12A lane 13).  MUC1 levels were rescued with the 
addition of FX and 50 mM lactate in hypoxic JEG-3 cells (12A lane 17) and levels were sustained 
with the addition of PA (12A lane 18).  The addition of PA and exogenous lactate further 
augmented MUC1 levels (12A lane 19).     
While the results presented herein are compelling, a clear trend between the expression of 
hypoxia-regulated proteins and intracellular lactate levels was largely absent.  However, the 
“Goldilocks” effect of lactate accumulation on trophoblast hypoxic signaling suggests an 
important role for lactate metabolism and indicates that potentially all players in this pathway have 
not yet been identified. 
3.3 In vivo functions of Ldhb 
The intricate quantitative and qualitative regulation of hypoxia-responsive proteins by 
lactate and its metabolites set the stage for the intriguing idea that lactate may be acting as a 
direct effector, or a precursor for one, in trophoblast hypoxic signaling.  This notion is not 
exclusive to the placenta, as it was previously demonstrated that lactate-stabilized NDRG3 signals 
through the MAP kinase axis to promote VEGF-mediated angiogenesis (Lee DC et al., 2015).  
LDHB is responsible for the conversion of lactate to pyruvate and is one of the most robust targets 
of placental PPARγ.  We reasoned that in the absence of PPARγ, lactate levels accumulate in 
trophoblasts and may contribute to the developmental defects observed in Pparg-null placentas.  
To directly approach this question, Ldhb-null mice were used to determine the effect of LDHB 
deficiency on placental development under steady state conditions and chronic hypoxic exposure. 
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3.3.1 LdhbΔ/Δ targeting and validation 
LdhbΔ/Δ mice were generated before the start of this project by previous Barak lab members 
(Sungeun Lee and Srinivas R. Pallerla).  Loxp sites flanking either side of exon 3 were inserted 
into the target allele using recombinant DNA technology (Figure 14A).  Maternal sox2-Cre was 
crossed with Ldhbfl/+ mice to globally delete the Ldhb floxed allele.  LdhbΔ/+ founders were 
backcrossed onto both B6 and 129 backgrounds for several generations before phenotypic analysis.  
Mice heterozygous for the mutation were crossed to generate WT, heterozygous, and null 
placentas.  Western blot analysis of E18.5 placentas confirms robust expression of LDHB in WT, 
reduced expression in heterozygotes, and complete deficiency in null animals (Figure 14B).    
 
 
Figure 3-14- Ldhb targeting and validation 
(A) Recombineering methodology was used to introduce loxp sites flanking exon 3 of the Ldhb gene.  The final 
targeting vector was introduced into ES cells, clones were selected for the correct integration in the Ldhb locus, and 
homologous recombinant clones were used to generate Ldhb-null mice.  (B) A Western blot of E18.5 placentas from 
WT and Ldhb-null embryos confirm the loss of LDHB protein in Ldhb-null placentas, as well as significant reduction 
in Ldhb-heterozygous placentas.  β-actin confirms equal sample loading in all lanes.    
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3.3.2 Phenotypic analysis of LdhbΔ/Δ mice 
 
Figure 3-15 - Ldhb-null placentas display no gross abnormalities 
Whole placentas (E12.5) were collected from WT and Ldhb-null embryos.  Placentas were fixed in neutralized 4% 
PFA, dehydrated in a graded EtOH series, and embedded in paraffin wax.  Midline cross sections (5 µm) were stained 
with H&E.  Dec – maternal decidua; TGC – trophoblast giant cell; JZ – junctional zone; Lab – labyrinth; CP – 
chorionic plate.  Ldhb-null placentas do not display any differences in gross morphology or cellular distribution. 
 
Under normal husbandry conditions, Ldhb-null mice are born at the expected Mendelian 
frequency with no observable changes in viability, health, or fertility.  Placentas collected from 
WT and Ldhb-null embryos at mid-gestation demonstrate that all placental layers are intact (i.e., 
chorion, labyrinth, JZ, and maternal decidua) and gross abnormalities in cellular distribution or 
layer formation are not detected (Figure 15).  This indicates that LDHB is not essential for 
placental development or embryonic survival and growth under standard conditions. 
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Figure 3-16- Hypoxic insult reduces labyrinth area in WT  embryos 
Dams pregnant with the product of heterozygous crosses were reared in 12% oxygen from E9.5 – 12.5.  Whole 
placentas were collected from WT and Ldhb-null embryos.  Placentas were fixed in neutralized 4% PFA, dehydrated 
in a graded EtOH series, and embedded in paraffin wax.  Midline cross sections (5 µm) were stained with H&E.  JZ 
– junctional zone; Lab – labyrinth.  Outline designates Lab-JZ border.    WT embryos reared in hypoxic conditions 
display an irregular Lab-JZ border and reduced total labyrinth volume. 
 
To test whether LDHB has important functions during chronic hypoxic exposure, heterozygous 
dams and sire were mated and housed under standard conditions or placed under 12% oxygen from 
E9.5-E12.5 to determine the effect of chronic hypoxic exposure on placental development in Ldhb-
null embryos (Figure 16).  Whole placentas collected from WT and LdhbΔ/Δ embryos from dams 
housed under normal ambient conditions were indistinguishable and displayed a typical labyrinth-
JZ border.   In contrast, WT placentas collected from embryos of hypoxic pregnancies displayed 
an irregular labyrinth-JZ border, possibly attributable to SpT invasion into the labyrinth or 
attenuated migration of SpT to the distal JZ, and Ldhb deficiency appeared to mitigate this effect.    
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3.3.3 Vascular analysis of LdhbΔ/Δ placentas 
While H&E staining is informative with respect to gross morphology and placental 
organization, in-depth information regarding labyrinth formation is difficult to deduce. Therefore, 
a reliable method to detect changes in the placental vascular architecture in response to genetic 
and environmental manipulation was critical for further investigation.  Confocal area scans were 
used to determine the effect of Ldhb deficiency on vascular tree formation and gain deeper insight 
into the role of hypoxia during placental development.  To that end, dams pregnant with Ldhb∆/+ 
intercrosses were housed in 12% O2 from E9.5-15.5 to simulate chronic hypoxic exposure.  At 
E15.5 embryos and placentas were assessed for viability, weighed, and genotyped.  There was 
relatively no change in embryonic or placental weight irrespective of genotype or hypoxic 
exposure.  Placentas were subsequently cryoembedded in OCT for IF analysis.  Midline sections 
were permeabilized and stained with α-CD31 (red; eBioScience) and α-Muc1 (green; 
ThermoFisher Scientific) to visualize the fetal blood vessels and maternal blood sinuses, 
respectively.  Images were acquired on a Nikon A1 confocal microscope equipped with a 
motorized stage and 20x objective to collect stepwise images.  The acquired image tiles were 
stitched together to generate a comprehensive overview of the vascular structure (Figure 17).  
There were no significant differences in WT or Ldhb-null placentas collected from 
normoxic pregnancies with respect to total labyrinth volume or vascular organization.  In contrast, 
the total labyrinth volume of hypoxic WT embryos placentas was significantly reduced compared 
to WT normoxic counterparts.  Ldhb deficiency appeared to ameliorate this effect, suggesting that 
the absence of LDHB is protective in conditions of reduced oxygen saturation.  Interestingly, the 
three hemochorial trophoblast layers of the labyrinth was intact in both WT and LdhbΔ/Δ placentas 
collected from hypoxic pregnancies (Figure 17, inset), confirming an underlying developmental, 
 61 
as opposed to structural, defect of WT hypoxic placentas.  Because LDHB is responsible for 
converting lactate to pyruvate, it is tempting to speculate that the protective effect observed is due  
 
Figure 3-17- Ldhb deficiency mitigates vascular defects in hypoxic placentas 
Ldhb∆/+ dams pregnant with the product of heterozygous crosses were randomly allocated to either standard or hypoxic 
(12% O2) conditions from E9.5-15.5   Midline serial sections of WT and Ldhb-null placentas were stained with α-
CD31 and α-Muc1 to visualize the fetal vessels and maternal blood sinuses, respectively.  Images were acquired on a 
Nikon Spectral A1 confocal microscope equipped with a 20x scanning objective and motorized stage to collect 
stepwise images.  The acquired image tiles were stitched together to generate a comprehensive overview of the 
vascular tree.  The total labyrinth area was quantified on whole area scans in the program Nis Elements.  Inset depicts 
the intimate association of fetal vessels and maternal blood sinuses.  Values were analyzed for significance with a 
two-way ANOVA and Tukey’s multiple comparisons test.  P < 0.05 was considered significant.  Labyrinth growth 
was stunted in WT placentas reared in hypoxia, while Ldhb deficiency mitigated this effect.   
 
to the accumulation of lactate, which may regulate factors that instruct trophoblast differentiation 
or promote fetal vessel angiogenesis.        
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3.4 In vitro genetic analyses of the trophoblast hypoxia-response pathway 
The effect of Ldhb deficiency on development of the placental vascular tree in hypoxic 
pregnancies was striking (see Figure 17), and solidified the notion that lactate production and 
clearance may have profound effects on trophoblast hypoxic signaling and subsequent placental 
development.  In addition, treatment of JEG-3 cells or TSCs with inhibitors of lactate metabolism 
revealed the complexities of intracellular lactate regulation and its effect on the expression of 
multiple hypoxia-responsive proteins in trophoblasts.  Given the non-specific nature of chemical 
inhibitors, and potential confounding off-target effects, a more precise method of interrogation 
was required.   To that end, CRISPR-Cas9 genetic engineering was used to delete key genes 
involved in the regulation of lactate metabolism in JEG-3 cells, including LDHB, PCX, PPARγ, 
and NDRG1, to further tease apart the regulatory properties of lactate in hypoxic trophoblasts.   
3.4.1 Generating the KOs 
To further delineate the PPARγ-HIF1α axis and determine the role of lactate metabolism 
in hypoxic trophoblasts, monoclonal cell lines with homozygous deletions of essential hypoxia-
regulatory proteins were generated.  A stable parent clone, containing dox-inducible Flag-Cas9 
expression, was generated first and served as the foundation for all subsequent genetic 
modifications.  To generate this clone, JEG-3 cells were transfected with a puro-resistant plasmid 
expressing the dox- dependent activator, rtTa, and TET-response element driven Flag-Cas9 
(Figure 18).  Individual puro-resistant colonies were selected, expanded, and incubated in the 
presence or absence of 1 µM dox.  Western blot analysis was used to determine the extent of Cas9 
induction post-stimulation.  
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As demonstrated in Figure 18, JEG clone 5.1, herein referred to as JEG 5.1, displayed 
undetectable levels of Flag-Cas9 at baseline, yet robust induction upon stimulation, and thus was 
chosen as the parent clone for further genetic modifications.  JEG 5.1 primed with dox for two  
 
 
Figure 3-18- Generation of monoclonal cell lines with dox-inducible Cas9 expression 
JEG-3 cells were transfected with a puro-resistant plasmid that expressed a dox-dependent activator of FLAG-Cas9.  
Individual puro-resistant clones were selected, expanded, and incubated in the presence or absence of 1 µM dox for 
two days and screened for the expression of Flag-Cas9 with α-FLAG M2 antibody.  JEG 5.1 produced high levels of 
Flag-Cas9 when stimulated as compared to undetectable levels at baseline, and therefore was selected as the parent 
clone for all subsequent genetic modifications.  Neo-resistant vectors containing guides directed against the target 
gene were subsequently transfected into JEG5.1, selected, and screened for appropriate genetic deletion. 
 
days to induce Cas9 expression, and then co-transfected with multiple vectors expressing 
neo resistance and sgRNAs directed against the gene of interest.  Colonies were selected with 
G418, expanded, and analyzed first by PCR to confirm deletion at both alleles of each gene and 
then by Western blot to confirm deficiency at the protein level.  All plasmids, sgRNAs and 
analytical oligos used are listed in appendices A and B, respectively. 
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3.4.1.1 PPARγ-/- trophoblasts are not viable 
sgRNAs were inserted in exons 6 and 7 of the human PPARG gene (Figure 19).  Very few 
clones survived selection, and even fewer were viable at the validation stage, and as such only one 
clone was generated.  Pparg-null JEG-3 cells proliferated at an extremely slow rate, exhibited 
reduced viability in culture, and had poor survival yield upon passaging.  Due to their slow growing 
nature and overall reduced viability, these cells could not be experimentally tested in hypoxia or 
otherwise.  However, this observation may provide useful insight into the role of placental PPARγ, 
as discussed later. 
 
 
Figure 3-19- PPARG targeting and validation 
Guides directed against exons 6 and 7 of the human PPARG gene were transfected into JEG 5.1 cells.  A graphical 
representation of gene targeting is provided for clarity.  (*) designate location of sgRNAs, and arrows represent the 
location of analytical oligos used for genotyping.  Western blot analysis confirms the loss of PPARγ protein in clone 
#24.3.  β-actin confirms equal sample loading in all lanes. 
 
3.4.1.2   LDHB deletion has no effect in hypoxic trophoblasts 
JEG 5.1 were transfected with guide RNAs targeted in exon 3, and introns 2 and 3, of the 
human LDHB gene as described above.  Colonies were selected based on PCR analysis of both 
WT LDHB alleles, expanded, and analyzed for the expression of LDHB (Figure 20).  LDHB 
protein was absent from all clones analyzed.  LDHB-/- cells displayed no overt changes in cell cycle 
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regulation (i.e., proliferation), morphology, or overall cell vitality, and thus were further 
interrogated to determine their hypoxic phenotype. 
 LDHB-/- cells were cultured under standard or hypoxic conditions for 6-48 h in the 
presence or absence of 1 µM Rosi.  LDHB protein was completely absent from clone #62.1, and 
slightly increased in parental JEG 5.1 cells in response to Rosi (Figure 21A and B) as expected 
(Shalom-Barak T et al., 2012).  The expression of PPARγ was relatively stable at all time points 
analyzed and, surprisingly, was sustained by 72 h in hypoxia in both WT and LDHB-null cells.  
Consistent with previous results, PPARγ protein levels slightly declined in the presence of Rosi 
(Figure 21B), indicative of negative feedback regulation.  HIF1α was undetectable in normoxic 
WT and LDHB-null cells (A – lane 1 and 7, B – lane 13 and 18) and remained stable throughout 
culture in hypoxia.  Additionally, NDRG1 expression increased throughout the course of hypoxic 
exposure, and levels were somewhat reduced in the presence of Rosi (Figure 21B), as shown 
earlier, irrespective of the presence or absence of LDHB.  Given these relatively unremarkable 
results, further LDHB-null clones were not analyzed. 
 
 
Figure 3-20- LDHB targeting and validation 
JEG 5.1 cells were transfected with sgRNAs directed against introns 2 and 3, and exon 3, of the human LDHB gene.  
A graphical representation of gene targeting is provided for clarity.  (*) designate location of sgRNAs, and arrows 
represent the location of analytical oligos used for genotyping.  Western blot analysis confirms the loss of LDHB 
protein in 2 clones.  β-actin confirms equal sample loading in all lanes.  
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3.4.2 PCX deletion negatively regulates hypoxia-responsive proteins 
Plasmids containing sgRNAs directed at exon 3 of the PC locus were introduced in JEG 
5.1 and subsequently selected, expanded, and analyzed for the expression of PCX protein.  Western 
blot analysis confirms the loss of PCX in null clones (Figure 22).  Morphology and lethality 
patterns were well conserved between WT and PC-null cells, yet PC-/- cells proliferated slower 
than the parental JEG 5.1 clone.  Considering that PCX catalyzes the carboxylation of pyruvate to 
form OAA, which is a critical intermediate in multiple metabolic pathways (Jitrapakdee S et al., 
1999).  It is likely that the absence of PCX causes a decline in intracellular OAA, effectively 
inhibiting production of a key building blocks required for demanding metabolic processes such 
as cell division.   
 
 
Figure 3-21 - Targeting and validation of PCX 
Plasmids containing sgRNAs targeted towards exon 3 of the human PC gene were transfected into JEG 5.1.  (*) 
designate location of sgRNAs, and arrows represent the location of analytical oligos used for genotyping.  Clones 
were generated as described previously and analyzed for the expression of PCX by Western blot    Western blot 
analysis confirms the loss of PCX in null clones.  β- actin indicates equal sample loading in all lanes. 
 
Despite decreased proliferation rates, PC-null cells were viable and therefore further 
interrogated to determine if PCX deficiency influences the expression of hypoxia-regulated 
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proteins.  JEG 5.1 (control) or PC-/- cells were cultured under either standard or hypoxic conditions 
6-48 h in the presence or absence of Rosi (Figure 23).  PC-null cells died by 48 h in hypoxia, 
irrespective of Rosi addition, precluding protein analysis.  Expression levels of PCX in JEG 5.1 
were stable throughout most of the hypoxic time course and declined by 48 h, potentially 
attributable to a concurrent decline in PPARγ protein (lane 5).  Rosi supplementation slightly 
increased PCX expression at all time points, as expected, as well as suppressed PPARγ levels, as 
shown before (lanes 5-10).  PPARγ protein in PC-null cells were comparable to control (lanes 11-
14) and were similarly suppressed by the addition of Rosi (lanes 15-18).       
PCX deficiency had no apparent effect on the expression of HIF1α in null cells in the 
absence of Rosi, and its levels were sustained up to 24 h in hypoxia (lanes 11-14).  In contrast, 
supplementation with Rosi suppressed HIF1α induction in PC-null cells (lanes 15-18) and  
 
Figure 3-22- PCX deficiency decreasees NDRG1 expression in hypoxia 
JEG 5.1 or PC-/- clone #18.3 were cultured under standard or hypoxic conditions for 6-48 h in the presence or absence 
of 1 µM Rosi.  NDRG1 protein levels were significantly decreased in PC-null cells as compared to control (5.1).  β-
actin confirms equal sample loading in all lanes.   
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significantly hastened its decline by 24 h, reflected in complete suppression of the lower MW band 
of the HIF1α doublet (lanes 15-18).   
Most importantly, PCX deletion had a profound influence on NDRG1 levels in hypoxic 
cultures.  Induction was substantially blunted and delayed irrespective of Rosi supplementation, 
with a slight increase by the 24 h mark (lanes 14, 18).  Rosi treatment slightly increased NDRG1 
levels compared to the untreated counterparts (lane 18).  This effect may correlate with the 
concomitant decline in PPARγ expression (lane 18), in line with the previously described 
properties of PPARγ as a negative regulator of NDRG1 expression.   
3.4.3  NDRG1 deletion had no effect on the expression of hypoxia-regulated proteins 
Guide RNAs directed towards exons 4 and 5 of the NDRG1 gene were introduced in JEG 
5.1 cells, and clones were selected based on their resistance to neo as described previously (see 
section 3.4.1).  Since NDRG1 is typically exclusively present in hypoxic trophoblasts, clones were 
cultured under hypoxic conditions for 24 h to confirm deletion of NDRG1 protein.  Indeed, 
NDRG1-null clones did not induce NDRG1 protein by 24 h in hypoxia as compared to JEG 5.1 
(Figure 24).  NDRG1-null cells displayed no differences in cell cycle regulation, gross morphology 
or overall cell viability in standard tissue culture conditions as predicted.    
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Figure 3-23- NDRG1 targeting and validation 
JEG 5.1 cells were transfected with plasmids containing sgRNAs targeted towards exons 4 and 5 of the human NDRG1 
gene.  (*) designate location of sgRNAs, and arrows represent the location of analytical oligos used for genotyping.  
JEG 5.1 and NDRG1-null cells were cultured under hypoxic conditions for 24 h.  Western blot analysis confirmed the 
loss of NDRG1 protein in hypoxia as compared to its retention in the parent clone JEG 5.1.  β-actin confirms equal 
sample loading in all lanes.     
 
Surprisingly, NDRG1 deficiency had no effect on the expression kinetics of any hypoxia- 
regulated proteins despite what appeared to be a complete KO by Western blotting.  The top band 
represents cross-reactivity of the polyclonal α-NDRG1 antibody (Figure 25).Because the  
 
 
Figure 3-24- NDRG1 deficiency has no effect on the expression of hypoxia-regulated proteins 
JEG 5.1 and NDRG1-/- clone #77.1 were reared under standard or hypoxic conditions from 6-72 h in the presence or 
absence of Rosi (1 µM).  NDRG1 deletion did not affect the expression of any hypoxia-regulated proteins.  β-actin 
confirms equal sample loading in all lanes.    
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stabilization of the NDRG family of proteins is reported to be positively regulated by lactate (Lee 
DC et al., 2015), the expression of LDHA was analyzed in addition to the standard suite of proteins 
tested in other KO lines.  LDHA induction slightly lagged behind the hypoxia-induced induction 
of HIF1α, consistent with HIF-dependent regulation of LDHA in hypoxic trophoblasts (Kay HH 
et al., 2007).  Moreover, time-dependent up-regulation of LDHA roughly coincided with the timing 
of NDRG1 upregulation in JEG 5.1, suggestive of close regulatory relationships and consistent 
with the expectation that increased lactate synthesis should further stabilize NDRG1 (Lee DC et 
al., 2015).  However, LDHA levels and induction kinetics were roughly similar irrespective of 
NDGR1 status in the cells.  Given the absence of dramatic effects in this NDRG1-null clone, 
additional null clones were not further analyzed. 
3.4.4 MUC1 deletion has disparate effects on the expression of hypoxic proteins 
MUC1-/- cells were generated as previously described (see section 3.4.1).  Briefly, plasmids 
containing sgRNAs targeted towards exon 7, and introns 6 and 7, of the human MUC1 gene were 
introduced in JEG 5.1 cells to selectively disrupt the C-terminal cytoplasmic tail (CT-2) domain.   
 
 
Figure 3-25- Muc1 targeting and validation 
JEG 5.1 cells were transfected with plasmids containing sgRNAs targeted towards exon 7 and introns 6 and 7 of the 
human MUC1 gene.  (*) designate location of sgRNAs, and arrows represent the location of analytical oligos used for 
genotyping.  Muc1 expression is completely abolished in null clones as confirmed by Western blot.  β-actin confirms 
equal sample loading in all lanes.     
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The CT-2 domain is proteolytically cleaved from the holo-Muc1 protein, and is believed 
to regulate the signaling functions of Muc1 in both the cytoplasm and the nucleus (Brayman M et 
al., 2004).  It was therefore targeted to ensure complete shutdown of downstream Muc1 signaling, 
although it is possible that other Muc1 variants containing the sialylated extracellular and 
transmembranal domains are still expressed in some KO combinations.  Western blot analysis 
confirms the loss of Muc1-CT2 protein in the 6 clones generated, with the parental clone JEG 5.1 
serving as a positive control (Figure 26).  Similar to PPARG-/- cells, MUC1-null cells were slow-
growing and died upon passaging, albeit to a lesser extent (~50% replating efficiency based on 
empirical observations).  Although the placental function of Muc1 is currently unclear (Shalom-
Barak T et al., 2004), this cellular defect, combined with recent reports that implicate Muc1 in 
HIF1α regulation (Chaika NV et al., 2012; Goudarzi H et al., 2013), enhanced the prospects that 
MUC1-/- cells would yield important information regarding the regulation of trophoblast hypoxic 
signaling. 
JEG 5.1 and two distinct MUC1-/- clones were cultured under standard or hypoxic 
conditions for 6-48 h in the presence or absence of Rosi (Figure 27).  Unlike the patterns observed 
in TSCs (Figures 1, 5 and Shalom-Barak T et al., 2004, 2012), in JEG 5.1 Muc1-CT2 was only 
induced by 24 h in hypoxia, and increased dramatically by the 48th h (lanes 4, 5, 9, 10, 24, 25, 29, 
30).  In another departure from TSCs, Rosi had no effect on Muc1-CT2 expression (lanes 9, 10, 
29, 30).  This striking discrepancy could reflect species-specific or lineage-specific differences 
between JEG-3 cells and TSCs.  As expected, both MUC1-null clones were completely devoid of 
Muc1-CT-2 expression (lanes 11-20, 31-40).   
Interestingly, a cross-reactive protein, migrating as an ~160 kDa band, was exclusively 
present in MUC1-/- clone #52.1 treated with Rosi at 6 and 12 h of hypoxic exposure (Figure 27 
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lanes 17-18).  Although this is odd, considering that the α-Muc1 mAb targets the excised CT2 
domain, the temporal regulation of this entity in hypoxia and its induction by Rosi akin to mouse 
Muc1 in TSCs (Shalom-Barak T et al., 2004; 2012) argues that this might be a bona fide 
alternative, uncleaved Muc1 isoform, which retained the corresponding epitope within the CT2 
domain.  Given the multiple possible CRISPR-mediated excision combinations with the four guide 
RNA sequences used to target MUC1 in JEG 5.1 (Figure 26), it is possible that the gene excision 
product in this clone produced an in-frame, albeit truncated, version of Muc1 that retains 
expression and some function.  This speculation is supported by the differential effects of the two 
tested MUC1-null clones on hypoxia-regulated proteins, as elaborated below.   
In MUC1-null clone #73.1 cells, HIF1α levels were as high at the 48th h of hypoxic 
exposure as in JEG 5.1 cells (Figure 27 lanes 25, 30, 35).  However, in the presence of Rosi clone 
#73.1 (right) exhibited a dramatic decrease in HIF1α levels by 48 h in hypoxia to below the 
detection threshold (lane 40).  A possible interpretation of this odd observation is that Muc1 is part 
of a finely tuned network of positive and negative regulators of HIF1α stability in hypoxia 
downstream of PPARγ, and its deletion disturbs the balance of this putative network.   
Compared to WT JEG 5.1 cells, MUC1 deficiency accelerated the decline of PPARγ 
protein in hypoxia in both KO cell lines (Figure 27 lanes 11-15, 31-35) and the addition of Rosi 
augmented this effect (lanes 16-20, 36-40), suggesting that Muc1 is required for long-term 
sustenance of both HIF1α and PPARγ expression in hypoxia. 
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Figure 3-26- MUC1-null cells have differential effects on trophoblast hypoxic signaling 
JEG 5.1 and MUC1-/- clone #52.1 (left) or clone #73.1 (right) were cultured under standard or hypoxic conditions from 
6-48 h in the presence or absence of Rosi (1 µM).  MUC1-null clones have differential effects on the regulation of 
hypoxia-responsive proteins.  β-actin confirms equal sample loading in all lanes. 
 
NDRG1 levels were similarly induced in untreated MUC1-null cells with expression 
observed by 24h in hypoxia (Figure 27 lane 14).  Importantly, the addition of Rosi was sufficient 
to significantly promote the expression of NDRG1 levels in normoxic MUC1-null cells and sustain 
expression up to 48 h in hypoxia exclusively in MUC1-/- clone #52.1 (lanes 16-20).  These data 
suggest that Muc1 may be the negative regulator of NDRG1, while PPARγ functions to simply 
regulate its expression, and by proxy, the expression of NDRG1.  The expression of NDRG1 
followed a similar pattern in JEG 5.1 and MUC1-null clone #73.1 cells, where expression was 
increased by 12 h in hypoxia, and Rosi had little to no effect.   
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4.0   Discussion 
4.1 The PPARγ-HIF1α-lactate axis in hypoxic trophoblasts 
This thesis describes the identification of a putative PPARγ-HIF1α signaling axis in 
hypoxic trophoblasts, whereby PPARγ is critical for their sustained HIF1α expression and 
prolonged survival.  A simplified model of this presumed pathway is illustrated in Figures 28 and 
29.  Hours after hypoxic insult, the intracellular levels of HIF1α are increased in response to the  
 
Figure 4-1- The potential role of PPARγ and its target genes under acute hypoxic conditions 
Proposed model for acute phase hypoxia in trophoblasts 
 
reduced hydroxylation capacity of its negative regulator, PHD2, resulting in an increase of free 
cytoplasmic HIF1α protein (Lee DC et al., 2015).  Monomeric HIF1α subsequently translocates to 
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the nucleus where it forms an obligate heterodimer with ARNT, binds to its cognate response 
element in the promoters of regulated genes, and activates the transcription of target genes (Koh 
My et al., 2012).  In the acute stage, the most relevant HIF1α target is LDHA and PDK1, which 
are responsible for the conversion of pyruvate to lactate and the reduction of pyruvate flux through 
the TCA cycle, respectively.  The enzymatic activity of LDHA is critical for generating the 
reducing equivalents required for sustained glycolysis and for maintaining ATP production under 
hypoxic conditions.  However, this reaction, in turn, increases intracellular lactate concentrations 
(Esterman A et al., 1997).  As demonstrated here, PPARγ is critical for lactate clearance in acute 
phase hypoxia.  This is reflected in the maintenance of basal lactate levels within the first 12 h of 
hypoxic exposure of WT TSCs, and the staggering accumulation of lactate in Pparg-null TSCs.  
This finding is fully consistent with the previous demonstration that PPARγ positively regulates 
two tandem enzymes, LDHB and PCX, that are synergistically responsible for lactate clearance 
(Shalom-Barak T et al., 2012).   
Exogenous lactate supplementation of hypoxic trophoblasts resulted in a decline in HIF1α.  
As intracellular lactate overload can contribute to cellular acidosis and lethality, this finding 
suggests that the pathway evolved with a negative feedback safety switch, in which excessive 
lactate accumulation, directly or through an intermediate, reins in HIF1α.  This thesis postulates 
that under acute hypoxic conditions, placental PPARγ suppresses intracellular lactate levels via 
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Figure 4-2- The potential role of PPARγ and its target genes under chronic hypoxic conditions 
Proposed model for chronic hypoxia in trophoblasts. 
 
positive regulation of LDHB and PCX, and functions as a countermeasure to maintain lactate 
concentrations at a relatively low level.  As shown, the requirement for PPARγ to sustain HIF1α 
levels in the chronic hypoxic phase likely occurs at the protein level, as no direct regulation at the 
RNA level was observed.  Based on the negative impact of high lactate concentrations on HIF1α 
levels, it is reasonable to hypothesize that this stabilizing effect is accomplished through the ability 
of PPARγ to rein in lactate accumulation.  This long-term stabilization, in turn, is critical for the 
activation of downstream signaling pathways that enable cells to survive a more chronic insult by 
facilitating adaptive gene networks, such as cellular differentiation, energy metabolism, and 
angiogenesis (Liu W et al., 2012).  Importantly, while PPARγ and HIF1a protein decay kinetics 
were accelerated in all WT TSC lines tested as compared to the GY11 clone ultimately chosen for 
in-depth analyses, the overall trends in the induction and regulation of hypoxia-responsive proteins 
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remained the same.  This confirms that the direct regulation of HIF1α by PPARγ was not a clonal 
artifact.  Importantly, treatment of WT and Pparg-null TSCs with CoCl2 was unable to mimic the 
effects of acute oxygen deprivation on the expression of hypoxia-regulatory proteins, further 
defining a role for the morphogenetic properties of oxygen in trophoblast biology.     
The flow of intracellular lactate levels in the early stages of hypoxia may also suppress 
NDRG1 levels.  This hypothesis arises from the ability of lactate for physical stabilization and 
activation of the downstream signaling properties of its close homolog, NDRG3, whose lactate 
binding motif is 100% identical to that of NDRG1 (Lee DC et al., 2015).  This notion is further 
validated by the observed inverse relationship between PPARγ and NDRG1.  Thus, under acute 
hypoxic conditions, the primary function of placental PPARγ may be to quell trophoblast lactate 
accumulation, which promotes sustained HIF1α stabilization and suppresses NDRG1 levels.  
However, this is only one part of the story, as NDRG1 is regulated by both PPARγ and hypoxia, 
at least in part, at the transcriptional level.   
As trophoblasts shift from acute to long-term hypoxic exposure (i.e., 24 h in hypoxia), 
PPARγ levels decline as previously published (Tache V et al., 2013), and as recapitulated here.  
This phenomenon was reported to be independent of both HIF and histone deacetylases (Tache V 
et al., 2013).  The decline of PPARγ protein in long-term hypoxic trophoblast cultures, and hence 
the positive effect exerted on both LDHB and PCX, is concomitant with an increase in intracellular 
lactate concentrations and NDRG1 levels.  It is tempting to hypothesize that the decreased activity 
of PPARγ and its target genes during chronic hypoxic exposure is directly responsible for the 
increased lactate accumulation, which subsequently leads to a rise in NDRG1 levels.  The 
possibility that NDRG1, in turn, contributes to the decline of HIF1α levels during chronic hypoxia, 
as reported in this dissertation and by others (Lee DC et al., 2015), is as intriguing.  One could 
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think of this phenomenon as “passing of the baton” as cells shift from acute hypoxia gene programs 
to more long-term adaptive gene networks, potentially driven by stabilized NDRG1, whose core 
function is still unknown (Choi SH et al., 2007; Shi XH et al., 2013; Larkin J et al., 2014). 
4.1.1 Implications in placental development and disease 
While the relative importance of PPARγ as an essential driver of placental development 
has been previously established (Barak Y et al., 1999), the function of placental PPARγ has yet to 
be elucidated.  This dissertation establishes a direct relationship between PPARγ and HIF1α in 
hypoxic trophoblasts as described above, and further implicates lactate as a potential mediator of 
the trophoblast hypoxic response.  Placentation initiates in a relatively hypoxic environment before 
establishment of the feto-placental vascular network (Weiss H et al., 2016).  The fine-tuned 
regulation of inter-tissue oxygen levels is essential for successful pregnancy, as demonstrated by 
the KOs of Hif1a, ARNT, and VHL (Cowden Dahl KD et al., 2005; Kozak KR et al., 1997; Takeda 
K et al., 2006; Gnarra JR et al., 1997).  In addition, previous studies have defined the role of oxygen 
sensing as a critical mediator of trophoblast differentiation (Tanaka S et al., 1998; Cowden Dahl 
KD et al., 2005).  Given novel relationship between PPARγ and HIF1α established here, and the 
overall phenotypic similarities shared between Pparg-, Hif1a, and Phd2-null placentas, the notion 
that the PPARγ-HIF1α axis may be primarily influencing trophoblast differentiation, and thus 
underpinning the placental defects observed in Pparg-null placentas, is definitely plausible.   
Indeed, Parast MM et al. (2009) previously demonstrated that under normoxic conditions 
Pparg-null TSCs fail to form the synTs that comprise the labyrinth and, rather, primarily 
differentiate into sTGCs, while hypoxic conditions reduced PPARγ expression levels independent 
of HIF1α activity and epigenetic regulation (Tache V et al., 2013).  Conversely, transcriptional 
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profiling in vivo and in vitro suggested that Pparg-null placentas and TSCs may have reduced 
capacity to differentiate into sTGCs (Shalom-Barak T et al., 2012).  The sTGCs form the first layer 
of the 3-cell trophoblast barrier in the mouse labyrinth and are in direct contact with the maternal 
blood (Rossant J et al., 2001).   Therefore, it is tempting to speculate that the PPARγ-HIF1α axis 
ultimately functions as a first-line sensor the placenta to promote trophoblast proliferation in the 
absence of oxygen, and differentiation to sTGCs upon reoxygenation.  Additionally, the complete 
vascularization failure of Pparg-null placentas, and its rescue by tetraploid complementation 
assays (Barak Y et al., 1999), indicates an underlying defect in trophoblast differentiation, as 
trophoblasts provide the framework into which the invading fetal vessels grow.  In the absence of 
a road map, the fetal vessels fail to vascularize the labyrinth (Rossant J et al., 2001).  Taken 
together, defects in the extended HIF pathway may ultimately underlie many of the placental and 
fetal defects associated with hypoxic insult during human pregnancy.  
4.2 Potential functions of lactate 
This thesis sheds a light on a previously unappreciated role of lactate in trophoblast hypoxic 
signaling.  As shown here, Pparg-null TSCs accumulate significantly more lactate in hypoxia 
compared to the WT counterparts, consistent with a putative role in the hypoxic signaling of 
trophoblasts. Moreover, treatment of JEG-3 cells with 100 mM exogenous lactate under normoxic 
conditions increases the expression of HIF1α, PPARγ, and NDRG1, providing a potential 
explanation for the elevated NDRG1 levels in normoxic Pparg-null TSCs.  Conversely, treatment 
of hypoxic JEG-3 cells or WT TSCs with inhibitors of lactate metabolism results in a near-
complete shutdown HIF1α, PPARγ, and NDRG1 protein levels within 24 h, demonstrating the 
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bidirectional influence of oxygen tension on the effect of lactate on hypoxia-responsive proteins.  
It is noteworthy that PPARγ levels did not decline in hypoxic JEG-3 cells by 24 h in hypoxia.  This 
could be attributable to the homogenous nature of JEG-3 cells, as opposed to the heterogenous cell 
populations in differentiated TSC cultures, and the likelihood that the expression of hypoxia-
regulated proteins in alternative cell populations, such as sTGCs, could have differential sensitivity 
to acute oxygen deprivation.  However, considering that the addition of exogenous lactate in 
combination with inhibitors of lactate metabolism to hypoxic trophoblasts further decreased, rather 
than promoted, the expression of HIF1α and additional proteins of interest, the role of lactate in 
the pathway is likely not as simplistic. 
The intricate relationships between lactate and the expression of hypoxia regulated proteins 
were further exemplified in the confounding effects of varying concentrations of Ox on differential 
regulation of HIF1α.  While treatment of hypoxic JEG-3 cells with 10 mM Ox enhanced the 
expression of HIF1α throughout the entirety of hypoxic exposure, higher Ox concentrations nearly 
abolished HIF1α expression completely.  Part of this ambiguity stems from the dual-action pan-
LDH inhibitor properties of Ox.  Later studies reveled that treatment of hypoxic JEG-3 cells with 
10 mM Ox slightly reduced the concentration of intracellular lactate by 12 h in hypoxia, albeit 
without statistical significance, while HIF1α levels were completely shut off.  However, HIF1α 
levels were sustained by 12 h in hypoxia in WT TSCs treated with 10 mM Ox, potentially 
indicating that JEG-3 cells are more sensitive to intracellular lactate manipulation due to their 
cancerous nature.  Treatment of JEG-3 cells with 40 mM Ox reduced intracellular lactate levels 
similar to that of 10 mM Ox yet diminished HIF1α levels by 6 h in hypoxia, prompting the notion 
that additional metabolites may be contributing to hypoxic protein regulation.  The disparate effect 
of lactate-mediated hypoxic protein regulation was further exemplified by 24 h in hypoxia.  
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Importantly, HIF1α, PPARγ, and NDRG1 levels were sustained in the presence or absence of high 
intracellular lactate concentrations, indicating that additional regulation, either at the metabolite or 
protein level, is involved in regulating the expression of hypoxic proteins during acute oxygen 
deprivation. 
While the results presented herein are intriguing, they still fall short of proving a clear 
causal link between the expression of hypoxia-regulated proteins and intracellular lactate levels.  
Disparate effects observed could be attributed to cellular acidosis, metabolic starvation, an 
undiscovered signaling intermediate, or differential metabolite regulation.  However, the totality 
of the observations here indicate that dysregulation of lactate metabolism severely impairs the 
hypoxic response of trophoblasts, suggesting that lactate, or by-products of its metabolism, is an 
essential regulatory node in the pathway.    
4.2.1 Additional metabolites measured 
Consistent with the hypothesis that additional metabolites or by-products of lactate 
metabolism may be influencing the expression of key hypoxic proteins of interest, multiple 
aqueous-phase metabolites were measured in hypoxic WT and Pparg-null TSCs at 12 h in hypoxia 
with non-targeted metabolomic profiling (Appendix F).  Citrate levels were relatively stable in 
WT and Pparg-null TSCs cultured under both normoxic and hypoxic conditions, strongly 
confirming that the marked intracellular lactate accumulation in hypoxic Pparg-null versus WT 
TSCs is significant and not an artifact of sample variability.  Three different metabolites - acetyl 
CoA, α-ketoglutarate, and malic acid – exhibited a similar differential pattern, whereby their 
concentrations decreased precipitously in normoxic Pparg-null compared to WT TSCs, but was 
restored in hypoxic conditions to the same level as in WT TSCs.  For acetyl CoA this reduction in 
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normoxic Pparg-null TSCs may indicate enhanced flux through the TCA cycle, decreased 
synthesis, or increased use as a substrate in anabolic reactions.  Its recovery to normal levels when 
mutant cells were transitioned to a hypoxic environment may suggest that the hypoxia response 
pathway either halted processes that accelerate its depletion or activated alternative PPARγ-
independent pathways for its synthesis.  The similar pattern of alpha ketoglutarate is notable in 
that not only is it a key TCA cycle intermediate but is also an essential hydroxyl donor to the 
HIF1α-destabilizing modification by PHD2.  In contrast, succinic acid accumulated in Pparg-null 
TSCs in both normoxia and hypoxia.  This significance and underpinnings of this accumulation 
are not clear.  All in all, these data are clearly indicative of differential cellular metabolism in 
Pparg-null versus WT TSCs, with more studies required for teasing apart the underlying 
mechanisms and physiological implications. 
4.2.2 Ldhb in the placenta 
Similar to the significant, albeit not fully resolved, role of lactate metabolism in hypoxic 
trophoblasts signaling, LDHB, and by proxy lactate metabolism and signaling, appeared to have 
an important role in hypoxic pregnancies.  The vascular labyrinth of WT placentas from hypoxic 
pregnancies was smaller, with irregular labyrinth-JZ boundaries, suggestive of SpT migration 
defect, and Ldhb deficiency appeared to mitigate this effect and restore gross placental and 
vascular structures to those seen in normoxic pregnancies.  
This evident discrepancy between WT and Ldhb-null placentas in hypoxic pregnancies 
suggests that similar to cultured trophoblasts, lactate metabolism is also a key regulator of the 
placental adaptative response to generalized hypoxia.  Future understanding of the underlying 
mechanism may require detailed interrogation of hypoxia-regulated proteins and various analytes, 
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in particular lactate, pyruvate, and oxidative respiration intermediates, to verify whether these 
indeed change in Ldhb-null placentas.  Nevertheless, these measurements might prove challenging.  
First, there is the technical caveat, which is a relatively lengthy placental dissection in ambient 
oxygen that may artificially erase hypoxia-driven differences by the time the samples are ready for 
analysis.  Second, considering that not all placental trophoblasts have the same sensitivity to 
hypoxic insults, and not all trophoblast lineages express Ldhb, it is likely that cellular and 
molecular differences could be localized to hot-spot locations within the developing placenta, 
which will be lost in whole tissue analysis. 
4.3 Lessons from CRISPR-Cas9-mediated KOs   
To facilitate the dissection of the intricate PPARγ-HIF1α-lactate axis in trophoblasts, 
monoclonal JEG-3 human choriocarcinoma clones carrying constitutive CRISP-Cas9-mediated 
deficiencies in PPARγ and hypoxia-signaling genes were generated.  Interrogated genes included 
PPARG, LDHB, PC, NDRG1, and MUC1.  Initial attempts to generate a cleaner system consisting 
of clones with conditional, dox-inducible KOs failed, due to both the relatively low efficiency of 
Cas9-mediated deletion coupled with the aneuploid nature of JEG-3 cells.  The default solution 
was to resort to clones with permanent deletion of each gene.  There were two major disadvantages 
to this backup strategy.  First, there is a theoretical risk that the lengthy selection process will be 
accompanied by random genetic deviations of individual clones, which will compromise 
comparison to “WT” JEG-3 cells.  Second, if any of the targeted genes has essential functions in 
JEG-3 cells, clones deficient for this gene will be hard to obtain and investigate.  With respect to 
the latter concern, it appears to have been realized with PPARG, and to a limited extent with 
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MUC1.  Although this in itself is valuable information, investigation of the signaling functions of 
each line was hampered. 
The deletion of PPARG in JEG 5.1 causes overt lethality, and therefore poor growth, 
resulting in poor survival of the majority of potential null clones and ultimately recovery of a single 
null clone that could not be expanded or preserved in any practical way.  While disappointing from 
a standpoint of the failure to use this approach to study the effect of this KO on hypoxic signaling, 
this observation provided some potential clues of the role of PPARγ in the placenta.  Because 
Pparg deficiency in TSCs is compatible with survival at both the differentiated and 
undifferentiated states, the initial observation that PPARG deficiency in JEG-3 cells results in 
complete lethality was surprising.  Therefore, it is possible that PPARγ is required for survival of 
only certain trophoblast lineages, which may manifest as a slightly skewed differentiation 
population that has gone unnoticed previously.  Gene expression data suggest broad failure of 
Pparg-null TSCs to express multiple markers of the sTGC lineage (Shalom-Barak T et al., 2012), 
and may lend support for this possibility.  This idea was not thought of or tested prior to this 
dissertation.  Another possibility is that PPARγ is essential in JEG-3 cells, potentially due to a 
need for its regulation of lactate metabolism, due to the cancerous nature of JEG-3 cells. 
PC-/- and MUC1-/- JEG-3 cells provided the most informative insights into hypoxia-
regulated proteins.  Hypoxia-driven induction of NDRG1 was severely impaired in PC-/- cells.  
Similar to PPARG-/- cells, MUC1-null cells were slow-growing and died upon passaging, albeit to 
a lesser extent that permitted ~50% cell survival.  Both MUC1-null clones generated were 
completely devoid of the CT-2 signaling domain, yet an alternative Muc1 product was exclusively 
present in MUC1-/- clone #52.1, and the temporal regulation of this truncated Muc1 product 
suggests that it may be a Muc1 isoform as opposed to background bands or cross-reactivity.  
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Because multiple guides directed against MUC1 were inserted in JEG 5.1, it’s entirely possible 
that this clone’s unique combination of Cas9-directed genetic cuts produces a functional version 
of Muc1, potentially through an in-frame deletion, that is capable of influencing protein 
expression.  Indeed, while the expression levels of NDRG1 were similarly induced in both 
untreated MUC1-null clones, the addition of Rosi was sufficient to significantly and exclusively 
promote the expression of NDRG1 levels in normoxic MUC1-/- clone #52.1 and sustain its 
expression in hypoxia.  These data suggest that Muc1 may be the negative regulator of NDRG1, 
while PPARγ functions to simply regulate its expression.  Alternatively, the Muc1 isoform in 
MUC1-/- clone #52.1 may function as a dominant negative, thereby increasing, as opposed to 
inhibiting, NDRG1 levels in hypoxia.   
Interestingly, neither LDHB nor NDRG1 deficiency had any significant effect on the 
expression of hypoxia-regulated proteins.  These results were both surprising and disappointing, 
given the profound effect of Ldhb deficiency on the vascular development of hypoxic placentas, 
and the robust induction of NDRG1 in hypoxia, its established relationship with lactate (Lee DC 
et al., 2015), and inverse relationship with PPARγ.  Still, these clones require further investigation 
into intracellular metabolite profiles both under normoxic and hypoxic conditions before definitely 
declaring the mutations asymptomatic.     
In summary, this dissertation unearthed a complex regulation of HIF1α levels by placental 
PPARγ and its transcriptional targets and proposes a new role for lactate metabolism in the hypoxic 
response of trophoblasts.  
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Appendix A – Plasmids 
Table 4 - Plasmids 
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Appendix B – sgRNAs and analytical oligos 
Table 5 - sgRNAs and analytical oligos 
 
E = exon; I = intron 
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Appendix C – Cell lines 
Table 6 - Cell lines 
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Appendix D – Antibodies 
Table 7- Antibodies 
 
 
 90 
Appendix E – Ligands and chemicals 
Table 8- Ligands and chemicals 
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Appendix F – Additional metabolites measured 
 
Figure A-1- Additional metabolites exhibit unique trends in Pparg-null cells 
WT (GY11; open circles) and Pparg-null (GY9; closed circles) TSCs were cultured under hypoxic conditions for 12 
h.  Metabolism was immediately quenched and analyte profiles determined with metabolomic analysis.  Values were 
analyzed using a two-way ANOVA and Tukey’s multiple comparisons test.  P < 0.05 was considered significant.  ND 
= not determined.  WT and Pparg-null TSCs displayed unique metabolic signatures at steady state and under hypoxic 
conditions.   
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